{"SLR NAME":"Meta-analysis of sociodemographic and clinical risk factors, laboratory parameters and treatments associated with higher mortality in COVID-19.","References":[{"title1":"Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study","References":[{"title2":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China","References":[{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"}]},{"title2":"Novel coronavirus (2019-nCoV)","References":[{"title3":"The psychological impact of quarantine and how to reduce it: rapid review of the evidence"},{"title3":"Impact of COVID-19 on Canadians"},{"title3":"A brief measure for assessing generalized anxiety disorder: the GAD-7"},{"title3":"Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis"},{"title3":"Psychological and behavioral impact of lockdown and quarantine measures for COVID-19 pandemic on children, adolescents and caregivers: a systematic review and meta-analysis"},{"title3":"Assessing the influence of parental anxiety on childhood anxiety during the COVID-19 pandemic in the United Arab Emirates"},{"title3":"Anxiety and depression symptoms, and lack of emotional support among the general population before and during the COVID-19 Pandemic. A prospective national study on prevalence and risk factors"},{"title3":"Initial challenges of caregiving during COVID-19: caregiver burden, mental health, and the parent-child relationship"},{"title3":"Well-being of parents and children during the COVID-19 Pandemic: a national survey"},{"title3":"The impact of COVID-19 on children with autism spectrum disorder"},{"title3":"Psychiatric disorders in children and adolescents during the COVID-19 pandemic"},{"title3":"Acute stress, behavioural symptoms and mood states among school-age children with attention-deficit/hyperactive disorder during the COVID-19 outbreak"},{"title3":"Post-secondary maternal education buffers against neural risk for psychological vulnerability to future life stress"},{"title3":"Clinical and psychological effects of excessive screen time on children"},{"title3":"Obesity and activity patterns before and during COVID-19 lockdown among youths in China"},{"title3":"Screen time for children and adolescents during the coronavirus disease 2019 pandemic"},{"title3":"COVID-19-related weight gain in school-aged children"},{"title3":"Obesity in children and adolescents during COVID-19 pandemic"},{"title3":"Weight gain in children during the covid-19 quarantine period"},{"title3":"SARS pandemic exposure impaired early childhood development: a lesson for COVID-19"},{"title3":"Increased screen time: implications for early childhood development and behavior"},{"title3":"Relationship between parenting practices and children's screen time during the COVID-19 pandemic in Turkey"},{"title3":"Applying harm reduction principles to address screen time in young children amidst the COVID-19 Pandemic"},{"title3":"Screen time young and children: promoting health and development in a digital world"},{"title3":"Influencing factors of screen time in preschool children: an exploration of parents' perceptions through focus groups in six European countries"},{"title3":"British families in lockdown: initial findings"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Novel coronavirus (2019-nCoV)","References":[{"title3":"The psychological impact of quarantine and how to reduce it: rapid review of the evidence"},{"title3":"Impact of COVID-19 on Canadians"},{"title3":"A brief measure for assessing generalized anxiety disorder: the GAD-7"},{"title3":"Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis"},{"title3":"Psychological and behavioral impact of lockdown and quarantine measures for COVID-19 pandemic on children, adolescents and caregivers: a systematic review and meta-analysis"},{"title3":"Assessing the influence of parental anxiety on childhood anxiety during the COVID-19 pandemic in the United Arab Emirates"},{"title3":"Anxiety and depression symptoms, and lack of emotional support among the general population before and during the COVID-19 Pandemic. A prospective national study on prevalence and risk factors"},{"title3":"Initial challenges of caregiving during COVID-19: caregiver burden, mental health, and the parent-child relationship"},{"title3":"Well-being of parents and children during the COVID-19 Pandemic: a national survey"},{"title3":"The impact of COVID-19 on children with autism spectrum disorder"},{"title3":"Psychiatric disorders in children and adolescents during the COVID-19 pandemic"},{"title3":"Acute stress, behavioural symptoms and mood states among school-age children with attention-deficit/hyperactive disorder during the COVID-19 outbreak"},{"title3":"Post-secondary maternal education buffers against neural risk for psychological vulnerability to future life stress"},{"title3":"Clinical and psychological effects of excessive screen time on children"},{"title3":"Obesity and activity patterns before and during COVID-19 lockdown among youths in China"},{"title3":"Screen time for children and adolescents during the coronavirus disease 2019 pandemic"},{"title3":"COVID-19-related weight gain in school-aged children"},{"title3":"Obesity in children and adolescents during COVID-19 pandemic"},{"title3":"Weight gain in children during the covid-19 quarantine period"},{"title3":"SARS pandemic exposure impaired early childhood development: a lesson for COVID-19"},{"title3":"Increased screen time: implications for early childhood development and behavior"},{"title3":"Relationship between parenting practices and children's screen time during the COVID-19 pandemic in Turkey"},{"title3":"Applying harm reduction principles to address screen time in young children amidst the COVID-19 Pandemic"},{"title3":"Screen time young and children: promoting health and development in a digital world"},{"title3":"Influencing factors of screen time in preschool children: an exploration of parents' perceptions through focus groups in six European countries"},{"title3":"British families in lockdown: initial findings"}]},{"title2":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","References":[{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"}]},{"title2":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Clinical Characteristics of Coronavirus Disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia","References":[]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China","References":[]},{"title2":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","References":[]},{"title2":"Editorial Concern-Possible Reporting of the Same Patients With COVID-19 in Different Reports","References":[]},{"title2":"Diagnosis and treatment protocols of pneumonia caused by a novel coronavirus (trial version 6)","References":[]},{"title2":"Diagnosis and treatment protocols of pneumonia caused by a novel coronavirus (trial version 7)","References":[]},{"title2":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected","References":[]},{"title2":"IMAI district clinician manual: hospital care adolescents and adults: guidelines for the management of illnessess with limited-resources","References":[]},{"title2":"Radiographic-clinical correlation in severe acute respiratory syndrome: study of 1373 patients in Hong Kong","References":[]},{"title2":"Clinical implication of radiographic scores in acute Middle East respiratory syndrome coronavirus pneumonia: Report from a single tertiary-referral center of South Korea","References":[{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"2014 MERS-CoV outbreak in Jeddah--a link to health care facilities"},{"title3":"MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study"},{"title3":"Managing MERS-CoV in the healthcare setting"},{"title3":"An appropriate Lower respiratory tract specimen is essential for diagnosis of Middle East Respiratory Syndrome (MERS)"},{"title3":"Fleischner Society: glossary of terms for thoracic imaging"},{"title3":"Association of radiologic findings with mortality in patients with avian influenza H7N9 pneumonia"},{"title3":"Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients"},{"title3":"CT correlation with outcomes in 15 patients with acute Middle East respiratory syndrome coronavirus"},{"title3":"Acute Middle East respiratory syndrome coronavirus: temporal lung changes observed on the chest radiographs of 55 patients"},{"title3":"Severe acute respiratory syndrome vs. The Middle East respiratory syndrome"},{"title3":"Middle East respiratory syndrome"},{"title3":"Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Successful treatment of suspected organizing pneumonia in a patient with Middle East respiratory syndrome coronavirus infection: a case report"}]},{"title2":"Acute respiratory distress syndrome: the Berlin Definition","References":[]},{"title2":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance","References":[]},{"title2":"Variance Inflation Factor: As a Condition for the Inclusion of Suppressor Variable(s) in Regression Analysis","References":[]},{"title2":"Portable chest X-ray in coronavirus disease-19 (COVID-19): A pictorial review","References":[{"title3":"CT features of coronavirus disease 2019 (COVID-19) pneumonia in 62 patients in Wuhan, China"},{"title3":"CT imaging features of 2019 novel coronavirus (2019-nCoV)"},{"title3":"ACR recommendations for the use of chest radiography and computed tomography (CT) for suspected COVID-19 infection|American College of Radiology. https://www.acr.org/Advocacy-and-Economics/ACR-Position-Statements/Recommendations-for-Chest-Radiography-and-CT-for-Suspected-COVID19-Infection. Accessed March 22, 2020. Google Scholar 2020."},{"title3":"Frequency and distribution of chest radiographic findings in COVID-19 positive patients"},{"title3":"Radiology of bacterial pneumonia"},{"title3":"Imaging profile of the COVID-19 infection: radiologic findings and literature review"},{"title3":"Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection"},{"title3":"Coronavirus disease 2019 (COVID-19): a systematic review of imaging findings in 919 patients"},{"title3":"Mediastinal emphysema, Giant Bulla, and pneumothorax developed during the course of COVID-19 pneumonia"},{"title3":"Fatal 2009 influenza a (H1N1) infection, complicated by acute respiratory distress syndrome and pulmonary interstitial emphysema"},{"title3":"Poston JT, Patel BK, Davis AM. Management of critically ill Adults with COVID-19. JAMA Clinical Guideline Synopsis. https://jamanetwork.com/journals/jama/fullarticle/2763879. Accessed March 26, 2020 2020."}]},{"title2":"Lung Ultrasound in the Diagnosis and Follow-up of Community-Acquired Pneumonia: A Prospective, Multicenter, Diagnostic Accuracy Study","References":[]},{"title2":"Lung ultrasound for the diagnosis of pneumonia in adults: a systematic review and meta-analysis","References":[]},{"title2":"A gross observational report of systematic autopsy in COVID-19 pneumonia","References":[]},{"title2":"Endothelial-platelet interactions in influenza-induced pneumonia: A potential therapeutic target","References":[]},{"title2":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","References":[{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Haematological changes in patients with severe acute respiratory syndrome"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS)"},{"title3":"Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome"},{"title3":"Clinical presentations and outcome of severe acute respiratory syndrome in children"},{"title3":"Molecular pathways in virus-induced cytokine production"},{"title3":"Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?"},{"title3":"In vivo studies on cytokine involvement during acute viral respiratory disease of swine: troublesome but rewarding"},{"title3":"Host defense response and outcome in ARDS"},{"title3":"The role of chemokines in the immunopathology of pulmonary disease"},{"title3":"Severe acute respiratory syndrome (SARS)"},{"title3":"Clinical applications of cytokine assays"},{"title3":"Cytometric bead array to measure six cytokines in twenty-five microliters of serum"},{"title3":"The cytokines: physiological and pathophysiological aspects"},{"title3":"Differential role of interleukin-6 in lung inflammation induced by lipoteichoic acid and peptidoglycan from Staphylococcus aureus"},{"title3":"Interleukin-10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression"},{"title3":"IL-12: a key cytokine in immune regulation"},{"title3":"Interleukin-12 regulates the proliferation of Th1, but not Th2 or Th0, clones"},{"title3":"Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones"},{"title3":"Interleukin 12: a key modulator of immune function"},{"title3":"Interleukin-12. Biologic activity, therapeutic utility, and role in disease"},{"title3":"Chemokines in acute lung injury"},{"title3":"Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome"},{"title3":"Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance"},{"title3":"The role of neutrophil elastase in acute lung injury"},{"title3":"Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS"},{"title3":"GRO alpha and interleukin-8 in Pneumocystis carinii or bacterial pneumonia and adult respiratory distress syndrome"},{"title3":"Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome"},{"title3":"Phenotypic characterization of alveolar monocyte recruitment in acute respiratory distress syndrome"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Distinct functions of interferon-gamma for chemokine expression in models of acute lung inflammation"},{"title3":"Induction of cytokines in mice with parainfluenza pneumonia"},{"title3":"Invited review. Cytokine regulation of fever: studies using gene knockout mice"},{"title3":"Chemokines in infectious diseases of the lung"},{"title3":"Anti-interleukin 8 autoantibody: interleukin 8 complexes in the acute respiratory distress syndrome. Relationship between the complexes and clinical disease activity"},{"title3":"Transforming growth factor-beta: a mediator of cell regulation in acute respiratory distress syndrome"},{"title3":"The strategy of blocking the chemokine system to combat disease"},{"title3":"Antichemokine immunotherapy for allergic diseases"}]},{"title2":"[Study on the levels of main inflammatory factors in septic shock and their clinical significance]","References":[]},{"title2":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","References":[{"title3":"The role of glucocorticoids as adjunctive treatment for sepsis in the modern era"},{"title3":"Corticosteroids for treating sepsis"},{"title3":"Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis"},{"title3":"Association of corticosteroid treatment with outcomes in adult patients with sepsis: a systematic review and meta-analysis"},{"title3":"Reevaluating the role of corticosteroids in septic shock: an updated meta-analysis of randomized controlled trials"},{"title3":"Can corticosteroids reduce the mortality of patients with severe sepsis? A systematic review and meta-analysis"},{"title3":"Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature"},{"title3":"Corticosteroids in sepsis: an updated systematic review and meta-analysis"},{"title3":"Effect of adjunctive corticosteroids on clinical outcomes in adult patients with septic shock-a meta-analysis of randomized controlled trials and trial sequential analysis"},{"title3":"Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis"},{"title3":"Adjunctive glucocorticoid therapy in patients with septic shock"},{"title3":"Hydrocortisone plus fludrocortisone for adults with septic shock"},{"title3":"2001 sccm/esicm/accp/ats/sis international sepsis definitions conference"},{"title3":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis"},{"title3":"Sepsis definitions: time for change"},{"title3":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)"},{"title3":"Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study"},{"title3":"Hydrocortisone Compared with Placebo in Patients with Septic Shock Satisfying the Sepsis-3 Diagnostic Criteria and APROCCHSS Study Inclusion CriteriaA Post Hoc Analysis of the ADRENAL Trial"},{"title3":"The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)"},{"title3":"Using big data to emulate a target trial when a randomized trial is not available"},{"title3":"The eICU Collaborative Research Database, a freely available multi-center database for critical care research"},{"title3":"Identifying patients with severe sepsis using administrative claims: patient-level validation of the angus implementation of the international consensus conference definition of severe sepsis"},{"title3":"FDA-Approved Drugs: SOLU-MEDROL U.S. FOOD &amp; DRUG Web site. Accessed 18 April 2020 https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process"},{"title3":"FDA-Approved Drugs: SOLU-CORTEF U.S. FOOD &amp; DRUG Web site. Accessed 18 April 2020 https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&amp;ApplNo=009866"},{"title3":"Early initiation of low-dose hydrocortisone treatment for septic shock in adults: a randomized clinical trial"},{"title3":"Reversal of late septic shock with supraphysiologic doses of hydrocortisone"},{"title3":"Immortal time bias in pharmacoepidemiology"},{"title3":"Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial"},{"title3":"Value of glucocorticoid steroids in the treatment of patients with severe community-acquired pneumonia complicated with septic shock"},{"title3":"Hydrocortisone therapy for patients with septic shock"},{"title3":"National analysis of sepsis hospitalizations and factors contributing to sepsis in-hospital mortality in Canada"},{"title3":"Glucose variability and mortality in patients with sepsis"},{"title3":"Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock"},{"title3":"The effect of comorbidity and age on hospital mortality and length of stay in patients with sepsis"},{"title3":"Adjusted survival curves with inverse probability weights"},{"title3":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples"},{"title3":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies"},{"title3":"Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis"},{"title3":"The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial"},{"title3":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock"},{"title3":"Effect of hydrocortisone on development of shock among patients with severe sepsis: the HYPRESS randomized clinical trial"},{"title3":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial"},{"title3":"Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial"},{"title3":"The effects of high-dose corticosteroids in patients with septic shock: a prospective, controlled study"},{"title3":"Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock"},{"title3":"Corticosteroids for treating sepsis in children and adults"},{"title3":"Steroids in the treatment of clinical septic shock"},{"title3":"Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes"},{"title3":"Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial"},{"title3":"Reduced cortisol metabolism during critical illness"},{"title3":"Cortisol levels and mortality in severe sepsis"},{"title3":"Why Test for Proportional Hazards?"},{"title3":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016"},{"title3":"Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes"}]},{"title2":"Coincidence of pro- and anti-inflammatory responses in the early phase of severe sepsis: Longitudinal study of mononuclear histocompatibility leukocyte antigen-DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients","References":[]},{"title2":"Neutrophil Activation During Septic Shock","References":[{"title3":"Predicting sepsis severity at first clinical presentation: The role of endotypes and mechanistic signatures"},{"title3":"NCBI GEO: Archive for functional genomics data sets--update"},{"title3":"Defining immunological dysfunction in sepsis: A requisite tool for precision medicine"},{"title3":"X-Tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization"},{"title3":"Sepsis and septic shock"},{"title3":"cytoHubba: identifying hub objects and sub-networks from complex interactome"},{"title3":"Contribution of prognostic ferroptosis-related subtypes classification and hub genes of sepsis"},{"title3":"Sepsis and septic shock: New definitions, new diagnostic and therapeutic approaches"},{"title3":"Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations"},{"title3":"Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron"},{"title3":"PhysioBank, PhysioToolkit, and PhysioNet: Components of a new research resource for complex physiologic signals"},{"title3":"Molecular mechanisms in septic shock (Review)"},{"title3":"A neutrophil elastase inhibitor, sivelestat, reduces lung injury following endotoxin-induced shock in rats by inhibiting HMGB1"},{"title3":"Blood transcriptome analysis of patients with uncomplicated bacterial infection and sepsis"},{"title3":"Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis"},{"title3":"MIMIC-IV"},{"title3":"Gasdermin D exerts anti-inflammatory effects by promoting neutrophil death"},{"title3":"Induction of the human gene for p44, a hepatitis-C-associated microtubular aggregate protein, by interferon-alpha/beta"},{"title3":"Wgcna: an R package for weighted correlation network analysis"},{"title3":"National inpatient hospital costs: The most expensive conditions by payer, 2017: Statistical brief #261"},{"title3":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2"},{"title3":"Endothelial dysfunction is an early indicator of sepsis and neutrophil degranulation of septic shock in surgical patients"},{"title3":"Distinguishing septic shock from non-septic shock in postsurgical patients using gene expression"},{"title3":"Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases"},{"title3":"Platelets and neutrophil extracellular traps collaborate to promote intravascular coagulation during sepsis in mice"},{"title3":"Sepsis 2018: Definitions and guideline changes"},{"title3":"Determining cell type abundance and expression from bulk tissues with digital cytometry"},{"title3":"Inhibition of neutrophil elastase prevents neutrophil extracellular trap formation and rescues mice from endotoxic shock"},{"title3":"Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps"},{"title3":"Hypoxia-related parameters during septic shock resuscitation: Pathophysiological determinants and potential clinical implications"},{"title3":"Physician variation in time to antimicrobial treatment for septic patients presenting to the emergency department"},{"title3":"IFI44 suppresses HIV-1 LTR promoter activity and facilitates its latency"},{"title3":"Recognizing sepsis as a global health priority - a WHO resolution"},{"title3":"Limma powers differential expression analyses for RNA-sequencing and microarray studies"},{"title3":"Current gaps in sepsis immunology: New opportunities for translational research"},{"title3":"Global, regional, and national sepsis incidence and mortality, 1990-2017: Analysis for the global burden of disease study"},{"title3":"Neutrophil to lymphocyte ratio as a predictor of treatment response and mortality in septic shock patients in the intensive care unit"},{"title3":"Classification of patients with sepsis according to blood genomic endotype: A prospective cohort study"},{"title3":"Developing a new definition and assessing new clinical criteria for septic shock: For the third international Consensus definitions for sepsis and septic shock (Sepsis-3)"},{"title3":"The third international Consensus definitions for sepsis and septic shock (Sepsis-3)"},{"title3":"Neutrophil activation during septic shock"},{"title3":"The STRING database in 2021: Customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets"},{"title3":"Bioinformatic analysis identifies potential biomarkers and therapeutic targets of septic-shock-associated acute kidney injury"},{"title3":"National inpatient hospital costs: The most expensive conditions by payer, 2011: Statistical brief #160"},{"title3":"National inpatient hospital costs: The most expensive conditions by payer, 2013: Statistical brief #204"},{"title3":"Neutrophil elastase and chronic lung disease"},{"title3":"A new method to measure the semantic similarity of GO terms"},{"title3":"Gene ontology semantic similarity analysis using GOSemSim"},{"title3":"GOSemSim: an R package for measuring semantic similarity among GO terms and gene products"},{"title3":"clusterProfiler: an R package for comparing biological themes among gene clusters"},{"title3":"A general framework for weighted gene co-expression network analysis"},{"title3":"Identification of hub genes for adult patients with sepsis via RNA sequencing"}]},{"title2":"The association between plasma D-dimer levels and community-acquired pneumonia","References":[{"title3":"Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy and prevention"},{"title3":"Ulusal Verilerle Toplum Kokenli Pnomoniler"},{"title3":"Epidemiology of community-acquired respiratory tract infections in adults: incidence, etiology and impact"},{"title3":"Infectiuous Diseases Society Of American /ATS consensus Guidelines on the management of community-acquired pneumonia adults"},{"title3":"D-dimer strategy in thrombosis exclusion--a gold standard study in 100 patients suspected of deep venous thrombosis or pulmonary embolism: 8 DD methods compared"},{"title3":"Nonspecific tests for pulmonary embolism"},{"title3":"D-dimer is an early diagnostic marker of coronary ischemia in patients with chest pain"},{"title3":"TAFI antigen and D-dimer levels during normal pregnancy and at delivery"},{"title3":"Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia"},{"title3":"A prediction rule to identify low-risk patients with community-acquired pneumonia"},{"title3":"Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults"},{"title3":"Practice guidelines for the management of community-acquired pneumonia in adults"},{"title3":"The lung"},{"title3":"Elevated concentrations of cross-linked fibrin degradation products in plasma"},{"title3":"Bedside measurement of D-dimer in the identification of bacteremia in the emergency department"},{"title3":"A rapid quantitative D-dimer assay at admission correlates with the severity of community acquired pneumonia"},{"title3":"Plasma D-dimer levels increase with the severity of community acquired pneumonia"},{"title3":"Plasma D-dimer levels correlate with outcomes in patients with community acquired pneumonia"},{"title3":"Admission D-dimer Can Identify Low-Risk Patients With Community-Acquired Pneumonia"},{"title3":"Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia"},{"title3":"D-dimer assay predicts mortality in critically ill patients without disseminated intravascular or venous thromboembolic disease"}]},{"title2":"[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia]","References":[]}]},{"title1":"Sociodemographic, clinical and laboratory factors on admission associated with COVID-19 mortality in hospitalized patients: A retrospective observational study","References":[{"title2":"Ministerio de Sanidad. Gobierno de Espana. Situacion de COVID-19 en Espana. Incidencia acumulada en los ultimos 14 dias. 2020; https://covid19.isciii.es/","References":[]},{"title2":"Ministerio de Sanidad. Gobierno de Espana. Actualizacion n  86. Enfermedad por el coronavirus (COVID-19). 2020; https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Actualizacion_86_COVID-19.pdf","References":[]},{"title2":"Ministerio de Sanidad. Gobierno de Espana. Actualizacion n  85. Enfermedad por el coronavirus (COVID-19). 2020; https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Actualizacion_85_COVID-19.pdf","References":[]},{"title2":"Clinical Characteristics of Coronavirus Disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths","References":[{"title3":"WHO. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200221-sitrep-32-covid-19.pdf?sfvrsn&amp;equals;4802d089_2. [Accessed on 21 February 2020]."},{"title3":"Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV"},{"title3":"2019 novel coronavirus disease (COVID-19) in Taiwan: reports of two cases from Wuhan, China"},{"title3":"A locally transmitted case of SARS-CoV-2 infection in Taiwan"},{"title3":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges"},{"title3":"Presumed asymptomatic carrier transmission of COVID-19"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period"},{"title3":"Clinical characteristics of 2019 novel coronavirus infection in China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China"},{"title3":"An interim review of the epidemiological characteristics of 2019 novel coronavirus"},{"title3":"Initial cluster of novel coronavirus (2019-nCoV) infections in Wuhan, China is consistent with substantial human-to-human transmission"},{"title3":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020"},{"title3":"Protecting health-care workers from subclinical coronavirus infection"},{"title3":"Neutrophil-to-lymphocyte ratio predicts severe illness patients with 2019 novel coronaviruse in the early stage"},{"title3":"CT imaging features of 2019 novel coronavirus (2019-nCoV)"},{"title3":"CT Imaging of the 2019 novel coronavirus (2019-nCoV) pneumonia"},{"title3":"Imaging changes in patients with 2019-nCov"},{"title3":"Chest CT findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: key points for the radiologist"},{"title3":"Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China"},{"title3":"Pre- and posttreatment chest CT findings: 2019 novel coronavirus (2019-nCoV) pneumonia"},{"title3":"Drug treatment options for the 2019-new coronavirus (2019-nCoV)"},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Arguments in favor of remdesivir for treating SARS-CoV-2 infections"},{"title3":"Chloroquine for the 2019 novel coronavirus"},{"title3":"Multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia. [Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia]"},{"title3":"Structure-activity relationship studies of lipophilic teicoplanin pseudoaglycon derivatives as new anti-influenza virus agents"},{"title3":"Glycopeptide antibiotics potently inhibit cathepsin L in the late endosome/lysosome and block the entry of Ebola virus, middle east respiratory syndrome coronavirus (MERS-CoV), and severe acute respiratory syndrome coronavirus (SARS-CoV)"},{"title3":"Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics"},{"title3":"Corticosteroid therapy for critically ill patients with middle east respiratory syndrome"},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients"},{"title3":"Factors associated with psychosis among patients with severe acute respiratory syndrome: a case-control study"},{"title3":"Glucocorticoid-induced diabetes in severe acute respiratory syndrome: the impact of high dosage and duration of methylprednisolone therapy"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"},{"title3":"Coronavirus infections and immune responses"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"2019-nCoV CDC Response Team. Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak - United States, December 31, 2019-February 4, 2020"},{"title3":"Controlling Middle East respiratory syndrome: lessons learned from severe acute respiratory syndrome"},{"title3":"Are children less susceptible to COVID-19?"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Informe sobre la situacion de COVID-19 en Espana. Informe de COVID-19 n  21. Red Nacional de Vigilancia Epidemiologica. 2020; https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/Documents/INFORMES/Informes%20COVID19/Informe%20n %2021.%20Situacion%20de%20COVID19%20en%20Espana%20a%206%20de%20abril%20de%202020.pdf","References":[]},{"title2":"World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). 2020; https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf","References":[]},{"title2":"Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention","References":[]},{"title2":"Imaging Profile of the COVID-19 Infection: Radiologic Findings and Literature Review","References":[{"title3":"Novel Coronavirus(2019-nCoV) Situation Report - 11"},{"title3":"Novel Coronavirus(2019-nCoV) Situation Report - 17"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Fleischner Society: glossary of terms for thoracic imaging"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"CT imaging features of 2019 Novel Coronavirus (2019-nCoV)"},{"title3":"Emerging Coronavirus 2019-nCoV Pneumonia"},{"title3":"CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia"},{"title3":"Severe acute respiratory syndrome: radiographic and CT findings"},{"title3":"Thin-section CT of severe acute respiratory syndrome: evaluation of 73 patients exposed to or with the disease"},{"title3":"Severe acute respiratory syndrome: radiographic evaluation and clinical outcome measures"},{"title3":"A Novel Coronavirus emerging in China - key questions for impact assessment"}]},{"title2":"Dynamic basic reproduction number-based evaluation for current prevention and control of COVID-19 outbreak in China","References":[]},{"title2":"CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)","References":[{"title3":"Novel Coronavirus - China. World Health Organization"},{"title3":"Novel Coronavirus (2019-nCoV). World Health Organization"},{"title3":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. World Health Organization"},{"title3":"Middle East respiratory syndrome Coronavirus (MERS-CoV). World Health Organization"},{"title3":"Situation report - 8. World Health Organization"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Fleischner Society: glossary of terms for thoracic imaging"},{"title3":"Radiographic and CT Features of Viral Pneumonia"},{"title3":"Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patients"},{"title3":"Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings"},{"title3":"Middle East respiratory syndrome-Coronavirus infection: a case report of serial computed tomographic findings in a young male patient"},{"title3":"About 2019 Novel Coronavirus (2019-nCoV). Centers for Disease Control and Prevention"},{"title3":"Radiologic pattern of disease in patients with severe acute respiratory syndrome: the Toronto experience"}]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Ministerio de sanidad. Gobierno de Espana. Informacion cientifico-tecnica. Enfermedad por coronavirus, COVID-19. 2020; https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertas%20Actual/nCov-China/documentos/20200404_ITCoronavirus.pdf","References":[]},{"title2":"Clinical and immunologic features in severe and moderate coronavirus disease 2019","References":[]},{"title2":"Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Clinical outcomes of current medical approaches for Middle East respiratory syndrome: A systematic review and meta-analysis","References":[{"title3":"Infectious diseases. MERS surges again, but pandemic jitters ease"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV)"},{"title3":"Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective descriptive study"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection"},{"title3":"Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: a report of nosocomial transmission"},{"title3":"Family cluster of Middle East respiratory syndrome coronavirus infections"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatment"},{"title3":"Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin"},{"title3":"Treatment with interferon-[alpha] 2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration"},{"title3":"Case report guidelines"},{"title3":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses"},{"title3":"Meta-analysis in clinical trials"},{"title3":"Measuring inconsistency in meta-analyses [journal article as teaching resource, deposited by John Flynn]"},{"title3":"Meta-analysis of genetic association studies"},{"title3":"Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches"},{"title3":"Post-dengue acute disseminated encephalomyelitis: a case report and meta-analysis"},{"title3":"MERS CoV infection in two renal transplant recipients: case report"},{"title3":"Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"A patient with severe respiratory failure caused by novel human coronavirus"},{"title3":"Ribavirin and interferon-alpha2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: a preliminary report of two cases"},{"title3":"Middle Eastern respiratory syndrome corona virus (MERS CoV): case reports from a tertiary care hospital in Saudi Arabia"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"Successful recovery of MERS CoV pneumonia in a patient with acquired immunodeficiency syndrome: a case report"},{"title3":"IFN-alpha2a or IFN-beta1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study"},{"title3":"Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen"},{"title3":"Middle East respiratory syndrome coronavirus in children"},{"title3":"Characteristics and outcomes of Middle East respiratory syndrome coronavirus patients admitted to an intensive care unit in Jeddah, Saudi Arabia"},{"title3":"A family cluster of Middle East respiratory syndrome coronavirus infections related to a likely unrecognized asymptomatic or mild case"},{"title3":"Infection prevention/control and management guidelines for patients with Middle East respiratory syndrome coronavirus (MERS CoV) infection"},{"title3":"Severe acute respiratory syndrome vs. the Middle East respiratory syndrome"}]},{"title2":"Prognostication in severe acute respiratory syndrome: a retrospective time-course analysis of 1312 laboratory-confirmed patients in Hong Kong","References":[{"title3":"  Summary of Probable SARS Cases with Onset of Illness from 1 November 2002 to 31 July, 2003 [Accessed 21 Apr 2004.] Available from URL: http://www.who.int/csr/sars/country/table2004_04_21/en "},{"title3":"  Update 4:Severe Acute Respiratory Syndrome (SARS) [Accessed 19 Mar 2003.] Available from URL: http://www.who.int/csr/sars/archive/2003_03_19/en "},{"title3":"  Alert, Verification and Public Health Management of SARS in the Post-outbreak Period [Accessed 14 Aug 2003.] Available from URL: http://www.who.int/csr/sars/postoutbreak/en "},{"title3":"  WHO Guidelines for the Global Surveillance of Severe Acute Respiratory Syndrome (SARS). Updated recommendations, October 2004. [Accessed 24 Jan 2005.] Available from URL: http://www.who.int/csr/resources/publications/WHO_CDS_CSR_ARO_2004_1/en/ "},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Severe acute respiratory syndrome: clinical outcome and prognostic correlates"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Serum LD1 isoenzyme and blood lymphocyte subsets as prognostic indicators for severe acute respiratory syndrome"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients"},{"title3":"Value of initial chest radiographs for predicting clinical outcomes in patients with severe acute respiratory syndrome"},{"title3":"Radiographic-clinical correlation in severe acute respiratory syndrome (SARS): a study of 1373 patients in Hong Kong"},{"title3":"  Severe Acute Respiratory Syndrome: What Do We Know About This Disease? [Accessed 2 Sep 2003.] Available from URL: http://www.fmshk.com.hk/hkmd/may2003/warfront2.htm "},{"title3":"The spectrum of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"  Guideline on the Management of Severe Acute Respiratory Syndrome (SARS). 19 March 2003 version. [Accessed 19 Mar 2003.] Available from URL: http://www.ha.org.hk "},{"title3":"  HA Guidelines on Severe Acute Respiratory Syndrome 10 April 2003 version. [Accessed 10 Apr 2003.] Available from URL: http://www.ha.org.hk "},{"title3":"Development of a standard treatment protocol for severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak"},{"title3":"The American-European Consensus Conference on ARDS, part 2: ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling. Acute respiratory distress syndrome"},{"title3":"Estimation of skin metabolism and blood flow with tcPO2 and tcPO2 electrodes by cuff occlusion of the circulation"},{"title3":"Simplified risk score models accurately predict the risk of major in-hospital complications following percutaneous coronary intervention"},{"title3":"The meaning and use of the area under a receiver operating characteristic (ROC) curve"},{"title3":"A review of goodness of fit statistics for use in the development of logistic regression models"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Do men have a higher case fatality rate of severe acute respiratory syndrome than women do?"},{"title3":"Clinical description of a completed outbreak of SARS in Vietnam, February-May 2003"},{"title3":"Hematological findings in SARS patients and possible mechanisms (Review)"},{"title3":"Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"Dynamic changes in blood cytokine levels as clinical indicators in severe acute respiratory syndrome"}]},{"title2":"StataCorp. 2017. Stata Statistical Software: Release 15. College Station, TX: StataCorp LLC.","References":[]},{"title2":"Centro Nacional de Epidemiologia. Red Nacional de Vigilancia Epidemiologica. Informe sobre la situacion de COVID-19 en Espana. Informe 14. 2020; https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/Documents/INFORMES/Informes%20COVID19/Informe%20n%C2%BA%2014.%20Situaci%C3%B3n%20de%20COVID19%20en%20Espa%C3%B1a%20a%2024%20marzo%20de%202020.pdf","References":[]},{"title2":"Demographic science aids in understanding the spread and fatality rates of COVID-19","References":[{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"},{"title3":"World Population Prospects"},{"title3":"A comparative perspective on intergenerational support"},{"title3":"Social contacts and mixing patterns relevant to the spread of infectious diseases"},{"title3":"The updates on COVID-19 in Korea as of 30 March"},{"title3":"Coronavirus disease"},{"title3":"Association of public health interventions with the epidemiology of the COVID-19 outbreak in Wuhan, China"},{"title3":"How will country-based mitigation measures influence the course of the COVID-19 epidemic?"}]},{"title2":"The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. Vital Surveillances: The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19). China CDC Wkly, 2020; http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51","References":[]},{"title2":"Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China","References":[]},{"title2":"Ministerio de Sanidad. Gobierno de Espana. Informacion cientifico-tecnica. Enfermedad por coronavirus, COVID-19. 2020; https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/20200417_ITCoronavirus.pdf","References":[]},{"title2":"Prevalence and duration of acute loss of smell or taste in COVID-19 patients","References":[{"title3":"The olfactory nerve is not a likely route to brain infection in COVID-19: a critical review of data from humans and animal models"},{"title3":"Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates"},{"title3":"SARS-CoV is associated with changes in brain structure in UK Biobank"},{"title3":"Development of the nervus terminalis in mammals including toothed whales and humans"}]},{"title2":"Olfactory Dysfunction and Sinonasal Symptomatology in COVID-19: Prevalence, Severity, Timing, and Associated Characteristics","References":[{"title3":"The SARS-CoV-2 outbreak: what we know"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Covid-19: WHO declares pandemic because of &quot;alarming levels&quot; of spread, severity, and inaction"},{"title3":"Clinical and virological data of the first cases of COVID-19 in Europe: a case series"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore"},{"title3":"Eleven faces of coronavirus disease"},{"title3":"Anosmia and ageusia: common findings in COVID-19 patients"},{"title3":"Isolated sudden onset anosmia in COVID-19 infection: a novel syndrome"},{"title3":"Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study"},{"title3":"COVID-19 anosmia reporting tool: initial findings"},{"title3":"Smell dysfunction: a biomarker for COVID-19"},{"title3":"Symptom scores as measures of the severity of rhinitis"},{"title3":"Sample size estimation in epidemiologic studies"},{"title3":"The outbreak of coronavirus disease 2019 (COVID-19): an emerging global health threat"},{"title3":"The COVID-19 pandemic in the US: a clinical update"},{"title3":"Covid-19: India imposes lockdown for 21 days and cases rise"},{"title3":"COVID-19 pandemic in West Africa"},{"title3":"Potential impact of seasonal forcing on a SARS-CoV-2 pandemic"},{"title3":"Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and myths"},{"title3":"Anosmia without nasal obstruction: a pathognomonic sign of COVID-19 infection"},{"title3":"Network HLB. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes [published online ahead of print April 23, 2020]. Nat Med. doi:10.1038/s41591-020-0868-6"},{"title3":"Single-cell RNA expression profiling shows that ACE2, the putative receptor of Wuhan 2019-nCoV, has significant expression in the nasal, mouth, lung and colon tissues, and tends to be co-expressed with HLA-DRB1 in the four tissues"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"},{"title3":"Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2"},{"title3":"Murine olfactory bulb interneurons survive infection with a neurotropic coronavirus"},{"title3":"Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study"},{"title3":"Association of chemosensory dysfunction and Covid-19 in patients presenting with influenza-like symptoms"},{"title3":"Patient recall and recall bias of health state and health status"}]},{"title2":"Tobacco smoking and COVID-19 pandemic: old and new issues. A summary of the evidence from the scientific literature","References":[{"title3":"Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention"},{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China"},{"title3":"COVID-19 Does Not Lead to a &quot;Typical&quot; Acute Respiratory Distress Syndrome"},{"title3":"COVID-19 pneumonia: different respiratory treatments for different phenotypes?"},{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Risk factors for primary middle east respiratory syndrome coronavirus illness in Humans, Saudi Arabia, 2014"},{"title3":"Sex difference and smoking predisposition in patients with COVID-19"},{"title3":"SeXX matters in immunity"},{"title3":"Sex hormones determine immune response"},{"title3":"X-chromosome-located microRNAs in immunity: might they explain male/female differences? The X chromosome genomic context may affect X-located miRNAs and downstream signaling, thereby contributing to the enhanced immune response of females"},{"title3":"Perche il coronavirus e piu mortale tra gli uomini che tra le donne. L'ipotesi tabagismo"},{"title3":"The First, Comprehensive Immunological Model of COVID-19. Implications for Prevention, Diagnosis, and Public Health Measures"},{"title3":"Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis"},{"title3":"Cigarette Smoking and Infection"},{"title3":"Impacts of cigarette smoking on immune responsiveness: up and down or upside down?"},{"title3":"Tobacco and the lung cancer epidemic in China"},{"title3":"Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease"},{"title3":"Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19)"},{"title3":"COVID-19 and smoking: A systematic review of the evidence"},{"title3":"Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis"},{"title3":"Smoking is Associated with COVID-19 Progression: A Meta-Analysis"},{"title3":"Smoking, vaping and hospitalization for COVID-19"},{"title3":"Low incidence of daily active tobacco smoking in patients with symptomatic COVID-19 infection"},{"title3":"A nicotinic hypothesis for COVID-19 with preventive and therapeutic implications"},{"title3":"The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review"},{"title3":"Susceptibility analysis of COVID-19 in smokers based on ACE2. Preprints 2020, 2020030078"},{"title3":"Cigarette smoke triggers the expansion of a subpopulation of respiratory epithelial cells that express the SARS-CoV-2 receptor ACE2"},{"title3":"ACE-2 Expression in the Small Airway Epithelia of Smokers and COPD Patients: Implications for COVID-19"},{"title3":"COVID-19 and Smoking. Nicotine &amp; Tobacco Research 2020"},{"title3":"Smoking history is an important risk factor for severe COVID-19"}]},{"title2":"COVID-19 and smoking: A systematic review of the evidence","References":[{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72.314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: A systematic review and meta-analysis"},{"title3":"COVID-19 and smoking: A systematic review of the evidence"},{"title3":"COVID-19 and smoking"},{"title3":"Patanavanich R, Glantz SA. Smoking is associated with COVID-19 progression: A meta-analysis. medRxiv preprint. doi: https://doi.org/10.1101/2020.04.13.20063669"},{"title3":"The impact of COPD and smoking history on the severity of Covid-19: A systemic review and meta-analysis"},{"title3":"Schopfel J. Towards a Prague definition of grey literature. Twelfth International Conference on Grey Literature: Transparency in Grey Literature. Grey Tech Approaches to High Tech Issues. Prague, 6-7 December 2010, Dec 2010, Czech Republic. pp. 11-26. sic_00581570 [consultado30 Abr 2020]. Disponible en: https://archivesic.ccsd.cnrs.fr/sic_00581570/document"},{"title3":"The PRISMA Group, Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement"},{"title3":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration"},{"title3":"Meta-analysis in clinical trials"},{"title3":"Diagnosis and treatment of adults with community-acquired pneumonia: An official clinical practice guideline of the American Thoracic Society and Infectious Disease Society of America"},{"title3":"Evidence-based medicine chapter of China International Exchange and Promotive Association for Medical and Health Care (CPAM). A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)"},{"title3":"Review Manager (RevMan) [programa informatico]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2014."},{"title3":"Prevalence of underlying diseases in hospitalized patients with COVID-19: A systematic review and meta-analysis"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Hu L, Chen S, Fu Y, Gao Z, Long H, Ren HW, et al. Risk factors associated with clinical outcomes in 323 COVID-19 patients in Wuhan, China. medRxiv preprint. doi: https://doi.org/10.1101/2020.03.25.20037721"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study"},{"title3":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study"},{"title3":"ACE-2 expression in the small airway epithelia of smokers and COPD patients: Implications for COVID-19"},{"title3":"Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China"},{"title3":"Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19)"},{"title3":"Ma Ch, Gu J, Hou P, Zhang L, Bai Y, Guo Z, et al. Incidence, clinical characteristics and prognostic factor of patients with COVID-19: A systematic review and meta-analysis. medRxiv preprint doi: https://doi.org/10.1101/2020.03.17.20037572."},{"title3":"Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease"},{"title3":"Wu C, Hu X, Song J, Du Ch, Xu J, Yang D, et al. Heart injury signs are associated with higher and earlier mortality in coronavirus disease 2019 (COVID-19). medRxiv preprint doi: https://doi.org/10.1101/2020.02.26.20028589."},{"title3":"Smoking, vaping and hospitalization for COVID-19"},{"title3":"COVID-19 with different severity: A multi-center study of clinical features"},{"title3":"Clinical feature of COVID-19 in elderly patients: A comparison with young and middle-aged patients"},{"title3":"Shu L, Wang X, Li M, Chen X, Shi L, Wu M, et al. Clinical characteristics of 545 cases confirmed COVID-19 in Wuhan Stadium Cabin Hospital. [consultado 1 May 2020]. Disponible en: https://ssrn.com/abstract=3552844 o http://dx.doi.org/102139/ssrn.3552844"},{"title3":"Comorbidity and its impact on 1590 patients with Covid-19 in China: A nationwide analysis"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Qi D, Yan X, Tang X, Peng J, Yu Q, Feng L, et al. Epidemiological and clinical features of 2019-nCoV acute respiratory disease cases in Chongqing municipality, China: A retrospective, descriptive, multiple-center study. medRxiv preprint. doi: https://doi.org/10.1101/2020.03.01.20029397"},{"title3":"Epidemiological and clinical features of 125 hospitalized patients with COVID-19 in Fuyang, Anhui, China"},{"title3":"CDC COVID-19 Response Team. Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019-United States, February 12-March 28, 2020. MMWR Morb Mortal Wkly Rep. 20203;69(13):382-386. doi: 10.15585/mmwr.mm6913e2."},{"title3":"Clinical course and outcomes of patients with severe acute respiratory syndrome coronavirus 2 infection: A preliminary report of the first 28 patients from the Korean Cohort Study on COVID-19"},{"title3":"Clinical features and treatment of COVID-19 patients in northeast Chongqing"},{"title3":"Host susceptibility to severe COVID-19 and establishment of a host risk score: Findings of 487 cases outside Wuhan"},{"title3":"Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study"},{"title3":"Clinical characteristics of Covid-19 in New York City"},{"title3":"Prediction for progression risk in patients with COVID-19 pneumonia: The CALL Score"},{"title3":"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan"},{"title3":"Risk factors for primary middle east respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014"},{"title3":"U.S. Department of Health and Human Services Center of Disease Control and Prevention. National Center for Chronic Disease Prevention and Health Promotion Office on Smoking and Health. Smoking Cessation. A report of the surgeon general. Atlanta, GA: 2020 [consultado 1 May 2020]. Disponible en: https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf"},{"title3":"Tobacco and waterpipe use increases the risk of suffering from COVID-19. World Health Organization (WHO) 2020 [consultado 1 May 2020]. Disponible en: http://www.emro.who.int/tfi/know-the-truth/tobacco-and-waterpipe-users-are-at-increased-risk-of-covid-19-infection.html"},{"title3":"Smoking Upregulates angiotensin-converting enzyme-2 receptor: A potential adhesion site for novel coronavirus SARS-CoV-2 (Covid-19)"},{"title3":"Naming the coronavirus disease (COVID-19) and the virus that causes it. World Health Organization (WHO) [consultado 1 Mayo 2020]. Disponible en: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it"}]},{"title2":"Predictors of Mortality for Patients with COVID-19 Pneumonia Caused by SARS-CoV-2: A Prospective Cohort Study","References":[]},{"title2":"COVID-19 Spiraling of Frailty in Older Italian Patients","References":[{"title3":"Frailty consensus: a call to action"},{"title3":"Physical Frailty: ICFSR International Clinical Practice Guidelines for Identification and Management"},{"title3":"Frailty in older adults: evidence for a phenotype"},{"title3":"International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management"},{"title3":"https://www.epicentro.iss.it, accessed March 28, 2020."},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 Feb 24. pii: S2213-2600(20)30079-5."},{"title3":"Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 11. pii: S0140-6736(20)30566-3."},{"title3":"A Multicenter Study of Multimorbidity in Older Adult Inpatients in China"},{"title3":"Prevalence, awareness, treatment, and control of hypertension in China: data from 1 7 million adults in a population-based screening study (China PEACE Million Persons Project)"},{"title3":"Distribution of type-1 and type-2 angiotensin receptors in the normal human lung and in lungs from patients with chronic obstructive pulmonary disease"},{"title3":"Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. J Virol. 2020 Mar 17;94(7)."},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola"},{"title3":"Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin-(1-7)"},{"title3":"Angiotensin converting enzyme 2: a new important player in the regulation of glycemia"},{"title3":"http://www.ansa.it/liguria/notizie/2020/03/27/covid-a-102-anni-si-ammala-e-guarisce_b3256ec4-c022-4fee-a553-cfc466531bcc.html, accessed March 28, 2020."},{"title3":"https://www.menshealth.com/uk/health/a31728622/coronavirus-survivor-covid/, accessed March 28, 2020"}]},{"title2":"Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19)-United States, February 12-March 16, 2020","References":[]},{"title2":"Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"The outbreak cases with the novel coronavirus suggest upgraded quarantine and isolation in Korea"},{"title3":"Current status of COVID-19 outbreak"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV)"}]},{"title2":"Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis","References":[]},{"title2":"Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy","References":[]},{"title2":"Unos 12.190 ancianos muertos en residencias de Espana con diagnostico o sintomas de coronavirus. El independiente, 2020. Available from: https://www.elindependiente.com/vida-sana/2020/04/17/cerca-de-12-190-ancianos-han-muerto-en-las-residencias-de-espana-con-diagnostico-o-sintomas-de-covid-19/","References":[]},{"title2":"Rapid Progression to Acute Respiratory Distress Syndrome: Review of Current Understanding of Critical Illness From COVID-19 Infection","References":[]},{"title2":"Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"The berlin definition of ARDS: an expanded rationale, justification, and supplementary material"},{"title3":"Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination"},{"title3":"Costimulation in antiviral immunity: differential requirements for CD4(+) and CD8(+) t cell responses. Curr==70=="},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"Middle east respiratory syndrome"},{"title3":"Multiple organ infection and the pathogenesis of Sars"},{"title3":"Middle east respiratory syndrome coronavirus efficiently infects human primary t lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"}]},{"title2":"Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers","References":[{"title3":"Comorbidities in COVID-19: outcomes in hypertensivecohort and controversies with renin angiotensin system blockers"},{"title3":"ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis"},{"title3":"Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. doi:10.1001/jamacardio.2020.1017. Published online March 27, 2020."},{"title3":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19"}]},{"title2":"Clinical Presentation of COVID-19: A Systematic Review Focusing on Upper Airway Symptoms","References":[]},{"title2":"Epidemiological characteristics of COVID-19 cases in Italy and estimates of the reproductive numbers one month into the epidemic","References":[]},{"title2":"World Health Organization (WHO). Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. 2020; https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected","References":[]},{"title2":"D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19","References":[{"title3":"From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses"},{"title3":"Multisystem effects of COVID-19: a concise review for practitioners"},{"title3":"Coagulation Dysfunction"},{"title3":"Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review"},{"title3":"Effect of mutation and vaccination on spread, severity, and mortality of COVID-19 disease"},{"title3":"Incidence of venous thromboembolism in hospitalized patients with COVID-19"},{"title3":"Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia"},{"title3":"Venous thromboembolism in patients with COVID-19: systematic review and meta-analysis"},{"title3":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"D-dimer level is associated with the severity of COVID-19"},{"title3":"COVID-19 and coagulation dysfunction in adults: a systematic review and meta-analysis"},{"title3":"Early changes in laboratory parameters are predictors of mortality and ICU admission in patients with COVID-19: a systematic review and meta-analysis"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Cytokine storm in COVID-19: the current evidence and treatment strategies"},{"title3":"The cytokine storm and COVID-19"},{"title3":"Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China"},{"title3":"IL-6 serum levels predict severity and response to tocilizumab in COVID-19: an observational study"},{"title3":"IL-6 and CD8+ T cell counts combined are an early predictor of in-hospital mortality of patients with COVID-19"},{"title3":"Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19"},{"title3":"Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients"},{"title3":"Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study"},{"title3":"Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2"},{"title3":"C-reactive protein levels in the early stage of COVID-19"},{"title3":"Prognostic value of C-reactive protein in patients with coronavirus 2019"},{"title3":"Dexamethasone in hospitalized patients with Covid-19"},{"title3":"Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis"},{"title3":"Corticosteroids for COVID-19"},{"title3":"A review of the evidence for corticosteroids in COVID-19"},{"title3":"The dynamics of procalcitonin in COVID-19 patients admitted to intensive care unit - a multi-centre cohort study in the South West of England, UK"},{"title3":"Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis"},{"title3":"Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis"},{"title3":"SARS-2 coronavirus-associated hemostatic lung abnormality in COVID-19: is it pulmonary thrombosis or pulmonary embolism?"},{"title3":"Coagulopathy of coronavirus disease 2019"},{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19"},{"title3":"Trends and diagnostic value of D-dimer levels in patients hospitalized with coronavirus disease 2019"},{"title3":"D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19"},{"title3":"D-dimer level is a useful predictor for mortality in patients with COVID-19: analysis of 483 cases"},{"title3":"Performance of diagnostic model for differentiating between COVID-19 and influenza: a 2-center retrospective study"},{"title3":"Comparison of the clinical and CT features between COVID-19 and H1N1 influenza pneumonia patients in Zhejiang, China"},{"title3":"Differential cytokine signatures of SARS-CoV-2 and influenza infection highlight key differences in pathobiology"},{"title3":"Platelet-driven coagulopathy in COVID-19 patients: in comparison to seasonal influenza cases"},{"title3":"Risk stratification of hospitalized COVID-19 patients through comparative studies of laboratory results with influenza"},{"title3":"Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China"},{"title3":"Impact of sex and gender on COVID-19 outcomes in Europe"}]},{"title2":"COVID-19 and its implications for thrombosis and anticoagulation","References":[]}]},{"title1":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","References":[{"title2":"Coronavirus: covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis","References":[{"title3":"Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis"},{"title3":"2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary"},{"title3":"Survival and left ventricular function changes in fulminant versus nonfulminant acute myocarditis"},{"title3":"Quantitative changes in late gadolinium enhancement at cardiac magnetic resonance in the early phase of acute myocarditis"},{"title3":"Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation"},{"title3":"Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease"},{"title3":"Efficacy and cardiovascular tolerability of continuous veno-venous hemodiafiltration in acute decompensated heart failure: a randomized comparative study"},{"title3":"Rapid resolution of acute fulminant myocarditis after IVIG and steroid treatment"},{"title3":"Fulminant myocarditis in children successfully treated with high dose of methyl-prednisolone"},{"title3":"Human parvovirus B19-associated myocarditis"},{"title3":"Effect of protein A immunoadsorption on T cell activation in patients with inflammatory dilated cardiomyopathy"},{"title3":"Use of the Impella 5.0 device as a bridge to recovery in adult fulminant viral myocarditis"},{"title3":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European society of cardiology working group on myocardial and pericardial diseases"},{"title3":"Myocarditis: a clinical overview"},{"title3":"Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care"},{"title3":"Corticosteroids for viral myocarditis"},{"title3":"Trimetazidine prevents macrophage-mediated septic myocardial dysfunction via activation of the histone deacetylase sirtuin 1"},{"title3":"Clinical outcomes in fulminant myocarditis requiring extracorporeal membrane oxygenation: a weighted meta-analysis of 170 patients"},{"title3":"Cardiac beta1-adrenoceptor autoantibodies in human heart disease: rationale and design of the Etiology, Titre-C ourse, and Survival (ETiCS) Study"},{"title3":"Extracorporeal membrane oxygenation for the support of adults with acute myocarditis"},{"title3":"Gamma-globulin treatment of acute myocarditis in the pediatric population"},{"title3":"Immunoadsorption therapy in dilated cardiomyopathy"},{"title3":"Echocardiographic findings in fulminant and acute myocarditis"},{"title3":"Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study"},{"title3":"Myocarditis"},{"title3":"Immune checkpoint inhibitorassociated myocarditis"},{"title3":"Fulminant myocarditis"},{"title3":"Intravenous immunoglobulin treatment for acute fulminant inflammatory cardiomyopathy: series of six patients and review of literature"},{"title3":"Guidelines for diagnosis and treatment of myocarditis (JCS 2009)"},{"title3":"Fulminant myocarditis"},{"title3":"Extracorporeal membranous oxygenation support for acute fulminant myocarditis: analysis of a single center's experience"},{"title3":"Analysis of ECMO treatment in five fulminant myocarditis patients"},{"title3":"The European study of epidemiology and treatment of cardiac inflammatory disease (ESETCID)"},{"title3":"Intra-aortic balloon pump"},{"title3":"Effect of intravenous immunoglobulin for fulminant myocarditis on in-hospital mortality: propensity score analyses"},{"title3":"Emerging pharmacologic targets and treatments for myocarditis"},{"title3":"Efficacy of circulatory support in patients with cardiogenic shock"},{"title3":"Fulminant myocarditis with combination immune checkpoint blockade"},{"title3":"Update on myocarditis"},{"title3":"Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance"},{"title3":"Interferon-Beta improves survival in enterovirus-associated cardiomyopathy"},{"title3":"Established and novel treatment options in acute myocarditis, with or without heart failure"},{"title3":"2011 consensus statement on endomyocardial biopsy from the association for European cardiovascular pathology and the society for cardiovascular pathology"},{"title3":"A life support based comprehensive treatment regimen dramatically lowers the in-hospital mortality of patients with fulminant myocarditis:a multiple center study"},{"title3":"Venoarterial extracorporeal membrane oxygenation for acute fulminant myocarditis in adult patients: a 5-year multi-institutional experience"},{"title3":"What's new in myocarditis"},{"title3":"Usefulness of cardiac biomarkers to predict cardiac recovery in patients on extracorporeal membrane oxygenation support for refractory cardiogenic shock"},{"title3":"Long-term prognosis of fulminant myocarditis rescued by percutaneous cardiopulmonary support device"},{"title3":"Virus serology in patients with suspected myocarditis: utility or futility"},{"title3":"Management of fulminant myocarditis: a diagnosis in search of its etiology but with therapeutic options"},{"title3":"Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea"},{"title3":"Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure"},{"title3":"Noninvasive ventilation in acute cardiogenic pulmonary edema: a meta-analysis of randomized controlled trials"},{"title3":"Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis"},{"title3":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012"},{"title3":"Statistical analysis on differences in different treatments for adults with fulminant myocarditis"},{"title3":"N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVECHF study"},{"title3":"Use of B-type natriuretic peptide for the management of women with dyspnea"},{"title3":"Prognosis of patients with fulminant myocarditis managed by peripheral venoarterial extracorporeal membranous oxygenation support: a retrospective single-center study"},{"title3":"Successive immunosuppressive treatment of fulminant myocarditis that is refractory to mechanical circulatory support"},{"title3":"Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure"},{"title3":"Transbrachial intra-aortic balloon pumping for a patient with fulminant myocarditis"},{"title3":"2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: executive summary"},{"title3":"Percutaneous mechanical circulatory support using Impella devices for decompensated cardiogenic shock"},{"title3":"Randomized, prospective trial of oxygen, continuous positive airway pressure, and bilevel positive airway pressure by face mask in acute cardiogenic pulmonary edema"},{"title3":"Pathophysiology of Takotsubo syndrome"},{"title3":"Echocardiographic findings in myocarditis"},{"title3":"Viral myocarditis-diagnosis, treatment options and current controversies"},{"title3":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure"},{"title3":"Veno-arterial extracorporeal membrane oxygenation for cardiogenic shock due to myocarditis in adult patients"},{"title3":"2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death"},{"title3":"Recomendaciones del Grupo de Trabajo Enfermedades Infecciosas (GTEI) de la Sociedad Espanola de Medicina Intensiva, Critica y Unidades Coronarias (SEMICYUC) y el Grupo de Estudio de Infecciones en el Paciente Critico (GEIPC) de la Sociedad Espanola de Enfermedades Infecciosas y Microbiologia clinica (SEIMC) para el diagnostico y tratamiento de la gripe A/H1N1 en pacientes adultos graves hospitalizados en las Unidades de Cuidados Intensivos"},{"title3":"Fulminant myocarditis: the role of cardiac magnetic resonance imaging"},{"title3":"Magnetic resonance imaging for characterizing myocardial diseases"},{"title3":"Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score"},{"title3":"Fc receptor-mediated inhibitory effect of immunoglobulin therapy on autoimmune giant cell myocarditis: concomitant suppression of the expression of dendritic cells"},{"title3":"Mechanical circulatory support in acute decompensated heart failure and shock"},{"title3":"Value of SOFA, APACHE IV and SAPS II scoring systems in predicting short-term mortality in patients with acute myocarditis"},{"title3":"Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABPSHOCK II): final 12 month results of a randomised, open-label trial"},{"title3":"Clinical analysis of 36 children with fulminant myocarditis"},{"title3":"Prognostic electrocardiographic parameters in patients with suspected myocarditis"},{"title3":"A national survey on myocarditis associated with the 2009 influenza A (H1N1) pandemic in Japan"},{"title3":"A national survey on myocarditis associated with influenza H1N1pdm2009 in the pandemic and postpandemic season in Japan"},{"title3":"Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock"},{"title3":"Contemporary management of cardiogenic shock: a scientific statement from the American heart association"},{"title3":"Detection and monitoring of acute myocarditis applying quantitative cardiovascular magnetic resonance"},{"title3":"Contemporary management of fulminant myocarditis"},{"title3":"Sixty-four cases of fulminant myocarditis in children"},{"title3":"Application of emergency coronary angiography in adult patients with fulminant myocarditis"},{"title3":"Meta-analysis: noninvasive ventilation in acute cardiogenic pulmonary edema"},{"title3":"Extracorporeal membrane oxygenation for rescuing fulminant myocarditis patients complicated with multiple organ failure"},{"title3":"Repetitive fulminant influenza myocarditis requiring the use of circulatory assist devices"},{"title3":"Intravenous immunoglobulin in the therapy of adult acute fulminant myocarditis: a retrospective study"},{"title3":"Mechanical support for cardiogenic shock"},{"title3":"Functional metabolomics characterizes a key role for N-acetylneuraminic acid in coronary artery diseases"},{"title3":"Clinical characteristics of old patients with fulminant myocarditis"}]}]},{"title1":"Characteristics and clinical outcomes of COVID?19 patients in an underserved?inner city population: A single tertiary center cohort","References":[{"title2":"Novel coronavirus:China","References":[]},{"title2":"  . 2020. COVID-19 Map. [online] Available at: &lt;https://coronavirus.jhu.edu/map.html&gt; Accessed May 2, 2020.","References":[]},{"title2":" https://www.inquirer.com/news/coronavirus-nursing-homes-philadelphia-data-farley-deaths-rates-20200503.html ","References":[]},{"title2":"  One Month Inside a Philly Hospital on the Front Lines of the COVID-19 Pandemic [Internet]. Philadelphia Magazine. Philadelphia Magazine; 2020 [cited 2020 Jun 14]. Available from: https://www.phillymag.com/news/2020/04/25/einstein-medical-center-coronavirus/. Accessed June 14, 2020.","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Covid-19 in critically ill patients in the Seattle region:case series","References":[{"title3":"Novel coronavirus : China"},{"title3":"Coronavirus COVID-19 global cases"},{"title3":"First case of 2019 novel coronavirus in the United States."},{"title3":"2019 Novel coronavirus outbreak (COVID-19)"},{"title3":"Cryptic transmission of novel coronavirus revealed by genomic epidemiology"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study."},{"title3":"Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response."},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State."},{"title3":"Priorities for the US health community responding to COVID-19."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Coronavirus disease 2019 (COVID-19)"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR."},{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"Early neuromuscular blockade in the acute respiratory distress syndrome."},{"title3":"Prone positioning in severe acute respiratory distress syndrome."},{"title3":"Bacterial coinfection in influenza: a grand rounds review."},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study."},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients."},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome."},{"title3":"Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis."},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China."},{"title3":"Care of the critically ill and injured during pandemics and disasters: groundbreaking results from the Task Force on Mass Critical Care."},{"title3":"Introduction and executive summary: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement."}]},{"title2":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State","References":[]},{"title2":"Presenting Characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area","References":[]},{"title2":"Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York","References":[{"title3":"Coronavirus disease 2019 (COVID-19) situation report - 87. Updated April 27, 2020"},{"title3":"Covid-19 in critically ill patients in the Seattle region:case series"},{"title3":"Coronavirus disease 2019 (COVID-19). Cases in the US. Updated April 26, 2020"},{"title3":"Coronavirus disease 2019 (COVID-19). COVID-19: Data. Updated April 27, 2020"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy"},{"title3":"2019 county health rankings key findings report"},{"title3":"Montefiore's Office of Community &amp; Population Health Bronx Community Health Dashboard: Nutrition, physical activity and obesity. Updated January 16, 2018. Accessed April 16, 2020. https://www.montefiore.org/documents/communityservices/OCPH-Dashboard-Obesity.pdf"},{"title3":"Centers for Disease Control and Prevention. Adult obesity prevalence maps. Division of Nutrition, Physical Activity, and Obesity, National Center for Chronic Disease Prevention and Health Promotion. Updated August 7, 2019. Accessed April 16, 2020. https://www.cdc.gov/obesity/data/index.html."},{"title3":"Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study"},{"title3":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy"},{"title3":"Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China"},{"title3":"Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China"},{"title3":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area"},{"title3":"Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease"},{"title3":"Importance of metabolic health in the era of COVID-19"},{"title3":"Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A (H1N1) disease"},{"title3":"Obesity and infection"},{"title3":"Obesity and its implications for COVID-19 mortality"},{"title3":"Obesity, inflammation and the immune system"},{"title3":"Obesity: the &quot;Achilles heel&quot; for COVID-19?"},{"title3":"Department of Health. Division of Chronic Disease Prevention: information for action reports"},{"title3":"QuickFacts. Bronx County (Bronx Borough), New York"},{"title3":"Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19)"}]},{"title2":"Distinct component profiles and high risk among african americans with metabolic syndrome","References":[]},{"title2":"The immunopathogenesis of sepsis in elderly patients","References":[]},{"title2":"Obesity and COVID-19 severity in a designated hospital in Shenzhen, China","References":[]},{"title2":"Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease","References":[{"title3":"Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease"},{"title3":"Nonalcoholic steatohepatitis: a review"},{"title3":"Effect of body mass index, metabolic health and adipose tissue inflammation on the severity of non-alcoholic fatty liver disease in bariatric surgical patients: a prospective study"},{"title3":"Applying non-invasive fibrosis measurements in NAFLD/NASH: progress to date"},{"title3":"Effects of laparoscopic sleeve Gastrectomy on non-alcoholic steatohepatitis and liver fibrosis in Japanese patients with severe obesity"},{"title3":"Non-alcoholic fatty liver disease: growing burden, adverse outcomes and associations"},{"title3":"Nonalcoholic steatohepatitis is associated with increased mortality in obese patients undergoing bariatric surgery"},{"title3":"Obesity is associated with severe forms of COVID-19"},{"title3":"Risk of COVID-19 for patients with obesity"},{"title3":"Lille Intensive Care COVID-19 and Obesity study group. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation"}]},{"title2":"Physiology of obesity and effects on lung function","References":[]},{"title2":"Obesity and infection","References":[{"title3":"Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus"},{"title3":"Epidemics of community-associated methicillin-resistant Staphylococcus aureus in the United States: a meta-analysis"},{"title3":"Impact of outpatient vs inpatient ABSSSI treatment on outcomes: a retrospective observational analysis of medical charts across US emergency departments"},{"title3":"Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis"},{"title3":"Novel application of published risk factors for methicillin-resistant S. aureus in acute bacterial skin and skin structure infections"},{"title3":"Skin and soft tissue infections and associated complications among commercially insured patients aged 0-64 years with and without diabetes in the U.S"},{"title3":"Once-weekly dalbavancin versus daily conventional therapy for skin infection"},{"title3":"A randomized clinical trial of single-dose versus weekly dalbavancin for treatment of acute bacterial skin and skin structure infection"},{"title3":"Dalbavancin for the treatment of acute bacterial skin and skin structure infections"},{"title3":"Single-dose dalbavancin and patient satisfaction in an outpatient setting in the treatment of acute bacterial skin and skin structure infections"},{"title3":"The use of confidence or fiducial limits illustrated in the case of the binomial"},{"title3":"Cellulitis: current insights into pathophysiology and clinical management"},{"title3":"Metabolic obesity phenotypes and risk of cellulitis: a cohort study"},{"title3":"Glycemic control and risk of cellulitis"},{"title3":"Obesity and heart failure as predictors of failure in outpatient skin and soft tissue infections"},{"title3":"OPAT For cellulitis: its benefits and the factors that predispose to longer treatment"},{"title3":"Diagnosis and management of cellulitis"},{"title3":"Safety of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSI): nephrotoxicity rates compared with vancomycin: a post hoc analysis of three clinical trials"},{"title3":"Single-dose oritavancin in the treatment of acute bacterial skin infections"},{"title3":"Single-dose oritavancin treatment of acute bacterial skin and skin structure infections: SOLO trial efficacy by Eron severity and management setting"},{"title3":"Efficacy and safety of omadacycline in patients with acute bacterial skin and skin structure infections (ABSSSI) and high body mass index or type 2 diabetes: a subgroup analysis from the OASIS trial"},{"title3":"Safety and efficacy of omadacycline in patients with diabetes in phase 3 clinical studies"},{"title3":"Comparison of delafloxacin (DLX) and vancomycin (VAN) in treatment of obese patients with acute bacterial skin and skin structure infections (ABSSSI)"},{"title3":"Treatment of acute bacterial skin and skin structure infection with single-dose dalbavancin in persons who inject drugs"}]},{"title2":"COVID-19 and African Americans","References":[{"title3":"COVID-19: a review on the novel coronavirus disease evolution, transmission, detection, control and prevention"},{"title3":"The third coronavirus epidemic in the third millennium: what's next?"},{"title3":"An interactive web-based dashboard to track COVID-19 in real time"},{"title3":"Long-term complications of COVID-19"},{"title3":"Association between COVID-19 and myocarditis using hospital-based administrative data - United States, March 2020-January 2021"},{"title3":"Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management"},{"title3":"Variants in SARS-CoV-2 associated with mild or severe outcome"},{"title3":"Mortality among US patients hospitalized with SARS-CoV-2 infection in 2020"},{"title3":"Features, Evaluation, and Treatment of Coronavirus (COVID-19)"},{"title3":"Cardiovascular disease and COVID-19"},{"title3":"Myocarditis after COVID-19 vaccination in a large health care organization"}]},{"title2":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients","References":[]},{"title2":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome","References":[]},{"title2":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","References":[]},{"title2":"Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial","References":[{"title3":"An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-beta-1a and hydroxychloroquine in hospitalized patients with COVID-19"},{"title3":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients"},{"title3":"Specialized interferon action in COVID-19"}]},{"title2":"No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection","References":[{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases"},{"title3":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomised clinical trial"},{"title3":"A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 COVID-19)"},{"title3":"Paradoxical effect of chloroquine treatment in enhancing Chikungunya virus infection"},{"title3":"A randomised controlled trial of chloroquine for the treatment of dengue in Vietnamese adults"},{"title3":"Chloroquine for influenza prevention: a randomised, double-blind, placebo-controlled trial"},{"title3":"Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomised controlled trial"}]},{"title2":"Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19","References":[{"title3":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro"},{"title3":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial"},{"title3":"The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin"},{"title3":"A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19"},{"title3":"Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data"},{"title3":"Assessment of QT intervals in a case series of patients with coronavirus disease 2019 (COVID-19) infection treated with hydroxychloroquine alone or in combination with azithromycin in an intensive care unit"},{"title3":"Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19)"},{"title3":"Against pandemic research exceptionalism"},{"title3":"Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19"},{"title3":"Observational study of hydroxychloroquine in hospitalized patients with Covid-19"},{"title3":"Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York state"},{"title3":"Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis"},{"title3":"Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy"},{"title3":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area"},{"title3":"Dosage of antimalarial drugs for children with juvenile rheumatoid arthritis and systemic lupus erythematosus. A clinical study with determination of serum concentrations of chloroquine and hydroxychloroquine"},{"title3":"Bioavailability of hydroxychloroquine tablets in healthy volunteers"},{"title3":"Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial"},{"title3":"Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 : COVID-NET, 14 states, March 1-30, 2020"},{"title3":"Disparities in outcomes among COVID-19 patients in a large health care system in California"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Statistical methods for analyzing right-censored length-biased data under cox model"},{"title3":"Performance of time-dependent propensity scores: a pharmacoepidemiology case study"},{"title3":"Performance evaluation of regression splines for propensity score adjustment in post-market safety analysis with multiple treatments"},{"title3":"Bias associated with using the estimated propensity score as a regression covariate"},{"title3":"Propensity score matching and subclassification in observational studies with multi-level treatments"},{"title3":"On principles for modeling propensity scores in medical research"}]},{"title2":"Effective treatment of severe COVID-19 patients with tocilizumab","References":[{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: An outbreak investigation"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study"},{"title3":"Extraordinary GU-rich single-strand RNA identified from SARS coronavirus contributes an excessive innate immune response"},{"title3":"Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: Implications for pathogenesis and treatment"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients"},{"title3":"Clinical experience of IL-6 blockade in rheumatic diseases-Implications on IL-6 biology and disease pathogenesis"},{"title3":"Interleukin-6 and its receptors: A highly regulated and dynamic system"},{"title3":"Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling"},{"title3":"Tocilizumab:a novel therapy for non-organ-specific autoimmune diseases"},{"title3":"Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: A randomised, double-blind, placebo-controlled, withdrawal phase III trial"},{"title3":"Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): A randomised, double-blind, controlled phase 4 trial"},{"title3":"Possible compartmental cytokine release syndrome in a patient with recurrent ovarian cancer after treatment with mesothelin-targeted CAR-T cells"}]},{"title2":"Tocilizumab treatment in COVID-19: a single center experience","References":[{"title3":"The trinity of COVID-19: immunity, inflammation and intervention."},{"title3":"Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells."},{"title3":"An inflammatory cytokine signature predicts COVID-19 severity and survival."},{"title3":"The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection."},{"title3":"Endothelial cell infection and endotheliitis in COVID-19."},{"title3":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19."},{"title3":"Immunotherapeutic implications of IL-6 blockade for cytokine storm."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"Neutrophils and lymphopenia, an unknown axis in severe COVID-19 disease."},{"title3":"Tocilizumab reduces COVID-19 mortality and pathology in a dose and timing-dependent fashion: a multi-centric study."},{"title3":"Effects of tocilizumab on neutrophil function and kinetics."},{"title3":"The neutrophil-to-lymphocyte ratio: a narrative review."},{"title3":"The neutrophil-lymphocyte count ratio in patients with community-acquired pneumonia."},{"title3":"Diagnostic and Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Early and Late Phase of Sepsis."},{"title3":"Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19."},{"title3":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China."},{"title3":"Lymphocyte blood levels that remain low can predict the death of patients with COVID-19."},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China."},{"title3":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province."},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome."},{"title3":"Neutrophil-to-Lymphocyte Ratio and Outcomes in Louisiana COVID-19 Patients."},{"title3":"Balenovic Krpan A, Begovac J, Civljak R, Dusek D, Kosanovic M, Lukas D, et al. Smjernice Klinike za infektivne bolesti ,,Dr. Fran Mihaljevic&quot; u Zagrebu i Hrvatskoga drustva za infektivne bolesti HLZ-a za antivirusno i imunomodulatorno lijecenje oboljelih od COVID-19 (verzija 2). Available from: https://bfm.hr/wp-content/uploads/2020/08/COVID-19-preporuke-za-lijecenje-v.2.-24.04.2020-1.pdf. Accessed January 9th 2023. (in Croatian)"}]},{"title2":"COVID-19 cytokine storm: the interplay between inflammation and coagulation","References":[{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice"},{"title3":"Targeting the 'cytokine storm' for therapeutic benefit"},{"title3":"Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome"},{"title3":"Proteinase-activated receptors in fibroproliferative lung disease"},{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Findings of acute pulmonary embolism in COVID-19 patients"},{"title3":"Vorapaxar in the secondary prevention of atherothrombotic events"},{"title3":"Regulation of neutrophilic inflammation in lung injury induced by community-acquired pneumonia"},{"title3":"Regulation of neutrophilic inflammation by proteinase-activated receptor 1 during bacterial pulmonary infection"},{"title3":"PAR-1 contributes to the innate immune response during viral infection"},{"title3":"PAR1 contributes to influenza A virus pathogenicity in mice"}]}]},{"title1":"Scoring systems for predicting mortality for severe patients with COVID-19","References":[{"title2":"The novel coronavirus originating in Wuhan, China: challenges for global health governance","References":[]},{"title2":"The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","References":[{"title3":"Influenza"},{"title3":"Norovirus classification and proposed strain nomenclature"},{"title3":"Wu, A. et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe10.1016/j.chom.2020.02.001 (2020)."},{"title3":"50 years of the International Committee on Taxonomy of Viruses: progress and prospects"},{"title3":"Gorbalenya, A. E., Lauber, C. &amp; Siddell, S. Taxonomy of Viruses, in Reference Module in Biomedical Sciences (Elsevier, 2019) 10.1016/B978-0-12-801238-3.99237-7."},{"title3":"The concept of virus species"},{"title3":"ICTV Code. The International Code of Virus Classification and Nomenclaturehttps://talk.ictvonline.org/information/w/ictv-information/383/ictv-code (2018)."},{"title3":"The molecular biology of coronaviruses"},{"title3":"Coronaviruses post-SARS: update on replication and pathogenesis"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Middle East respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Snijder, E. J. et al. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J. Mol. Biol.331, 991-1004 (2003)."},{"title3":"van Boheemen, S. et al. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. mBio3, e00473-12 (2012)."},{"title3":"Additional changes to taxonomy ratified in a special vote by the International Committee on Taxonomy of Viruses (October 2018)"},{"title3":"Ziebuhr, J. et al. Proposal 2017.013S. A.v1. Reorganization of the family Coronaviridae into two families, Coronaviridae (including the current subfamily Coronavirinae and the new subfamily Letovirinae) and the new family Tobaniviridae (accommodating the current subfamily Torovirinae and three other subfamilies), revision of the genus rank structure and introduction of a new subgenus rank. (ICTV, 2017); https://ictv.global/proposal/2017.Nidovirales/."},{"title3":"Ziebuhr, J. et al. Proposal 2019.021S.Ac.v1. Create ten new species and a new genus in the subfamily Orthocoronavirinae of the family Coronaviridae and five new species and a new genus in the subfamily Serpentovirinae of the family Tobaniviridae. (ICTV, 2019); https://ictv.global/proposal/2019.Nidovirales/."},{"title3":"de Groot, R. J. et al. in Virus Taxonomy, Ninth Report of the International Committee on Taxonomy of Viruses (eds King, A. M. Q. et al.) 806-828 (Elsevier Academic Press, 2012)."},{"title3":"Toward genetics-based virus taxonomy: comparative analysis of a genetics-based classification and the taxonomy of picornaviruses"},{"title3":"The species problem in virology"},{"title3":"Partitioning the genetic diversity of a virus family: approach and evaluation through a case study of picornaviruses"},{"title3":"Mesoniviridae: a new family in the order Nidovirales formed by a single species of mosquito-borne viruses"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Zhou, P. et al. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. Nature10.1038/s41586-020-2012-7 (2020)."},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Gorbalenya, A. E. et al. The new scope of virus taxonomy: partitioning the virosphere into 15 hierarchical ranks. Nat. Microbiol. (in the press)."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Kui, L. et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin. Med. J. 10.1097/CM9.0000000000000744 (2020)."},{"title3":"Li, Q. et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N. Engl. J. Med. 10.1056/nejmoa2001316 (2020)."},{"title3":"Liu, Y., Gayle, A. A., Wilder-Smith, A. &amp; Rocklov, J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J. Travel Med. 10.1093/jtm/taaa021 (2020)."},{"title3":"Estimation of the transmission risk of the 2019-nCoV and its implication for public health interventions"},{"title3":"Novel Coronavirus (2019-nCoV) Situation Report - 22 (World Health Organization, 2020); https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200211-sitrep-22-ncov.pdf"},{"title3":"Coronavirus disease (COVID-19) outbreak (World Health Organization, 2020); https://www.who.int/emergencies/diseases/novel-coronavirus-2019"},{"title3":"World Health Organization best practices for the naming of new human infectious diseases (World Health Organization, 2015); https://apps.who.int/iris/handle/10665/163636"},{"title3":"A nomenclature for avian coronavirus isolates and the question of species status"},{"title3":"Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae"},{"title3":"Molecular evolution of human coronavirus genomes"},{"title3":"PCR assays for detection of human astroviruses: In silico evaluation and design, and in vitro application to samples collected from patients in the Netherlands"},{"title3":"Binomial nomenclature for virus species: a consultation"},{"title3":"Practical application of bioinformatics by the multidisciplinary VIZIER consortium"},{"title3":"IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies"},{"title3":"Filterable viruses: a critical review"},{"title3":"The global virome project"},{"title3":"Expanding the RNA virosphere by unbiased metagenomics"},{"title3":"ICD-11 (World Health Organization, 2018)."},{"title3":"Hosts and sources of endemic human coronaviruses"},{"title3":"A comparative sequence analysis to revise the current taxonomy of the family Coronaviridae"},{"title3":"A planarian nidovirus expands the limits of RNA genome size"},{"title3":"Recombination in large RNA viruses: Coronaviruses"},{"title3":"Molecular epidemiology, evolution and phylogeny of SARS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Complete genome sequence of a severe acute respiratory syndrome-related coronavirus from Kenyan bats"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Viral evolution and the emergence of SARS coronavirus"},{"title3":"Evidence of the recombinant origin of a bat severe acute respiratory syndrome (SARS)-like coronavirus and its implications on the direct ancestor of SARS coronavirus"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate","References":[]},{"title2":"Strategies to control COVID-19 and future pandemics in Africa and around the globe","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan","References":[{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV)"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases"},{"title3":"Diagnosis and treatment of adults with community-acquired pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention [published online ahead of print February 24, 2020]. JAMA. https://doi.org/10.1001/jama.2020.2648."},{"title3":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China [published online ahead of print February 28, 2020]. N Engl J Med. https://doi.org/10.1056/NEJMoa2002032."},{"title3":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS"},{"title3":"Severe acute respiratory syndrome: clinical and laboratory manifestations"},{"title3":"Clinical manifestations and inflammatory cytokine responses in patients with severe acute respiratory syndrome"},{"title3":"SARS immunity and vaccination"},{"title3":"Prevalence, risk factors, and management of asthma in China: a national cross-sectional study"},{"title3":"Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China [published online ahead of print February 19, 2020]. Allergy. https://doi.org/10.1111/all.14238."},{"title3":"An increased prevalence of self-reported allergic rhinitis in major Chinese cities from 2005 to 2011"},{"title3":"ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation"},{"title3":"Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection"},{"title3":"Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes"},{"title3":"Wu C, Chen X, Cai Y, Xia Ja, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China [published online ahead of print March 13, 2020]. JAMA Intern Med. https://doi.org/10.1001/jamainternmed.2020.0994."},{"title3":"Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis [published online ahead of print March 26, 2020]. Eur Respir J. https://doi.org/10.1183/13993003.00547-2020."},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Diagnostic and prognostic value of very high serum lactate dehydrogenase in admitted medical patients"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study [published online ahead of print February 24, 2020]. Lancet Respir Med. https://doi.org/10.1016/S2213-2600(20)30079-5."},{"title3":"Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19 [published online ahead of print March 18, 2020]. N Engl J Med. https://doi.org/10.1056/NEJMoa2001282."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Lan L, Xu D, Ye G, Xia C, Wang S, Li Y, et al. Positive RT-PCR test results in patients recovered from COVID-19 [published online ahead of print February 27, 2020]. JAMA. https://doi.org/10.1001/jama.2020.2783."},{"title3":"Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, Bibi S, et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? [published online ahead of print February 22, 2020] Int J Epidemiol. https://doi.org/10.1093/ije/dyaa033."}]},{"title2":"A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy","References":[{"title3":"Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis"},{"title3":"Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury"},{"title3":"The severity of acute kidney injury predicts progression to chronic kidney disease"},{"title3":"KDIGO Clinical Practice Guideline for Acute Kidney Injury"},{"title3":"European best practice quo vadis? From European Best Practice Guidelines (EBPG) to European Renal Best Practice (ERBP)"},{"title3":"Acute renal failure:definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group"},{"title3":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury"},{"title3":"Defining acute kidney injury: playing hide-and-seek with the unknown man?"},{"title3":"A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients"},{"title3":"The magnitude of acute serum creatinine increase after cardiac surgery and the risk of chronic kidney disease, progression of kidney disease, and death"},{"title3":"A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients"},{"title3":"RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis"},{"title3":"NCEPOD report on acute kidney injury-must do better"},{"title3":"Commonly used surrogates for baseline renal function affect the classification and prognosis of acute kidney injury"},{"title3":"The calculation of baseline serum creatinine overestimates the diagnosis of acute kidney injury in patients undergoing cardiac surgery"},{"title3":"Back-calculating baseline creatinine with MDRD misclassifies acute kidney injury in the intensive care unit"},{"title3":"A comparison of three methods to estimate baseline creatinine for RIFLE classification"},{"title3":"Toward the optimal dose metric in continuous renal replacement therapy"},{"title3":"Defining urine output criterion for acute kidney injury in critically ill patients"},{"title3":"The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies"},{"title3":"How to use biomarkers efficiently in acute kidney injury"},{"title3":"Incidence and outcomes of acute kidney injury in a referred chronic kidney disease cohort"},{"title3":"Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study"},{"title3":"Residual urine output and postoperative mortality in maintenance hemodialysis patients"},{"title3":"Fluid balance, diuretic use, and mortality in acute kidney injury"},{"title3":"Early goal-directed therapy in the treatment of severe sepsis and septic shock"},{"title3":"Intensive insulin therapy and pentastarch resuscitation in severe sepsis"},{"title3":"Colloid solutions for fluid resuscitation"},{"title3":"Effect of norepinephrine on the outcome of septic shock"},{"title3":"Use of dopamine in acute renal failure: a meta-analysis"},{"title3":"Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death"},{"title3":"Does perioperative hemodynamic optimization protect renal function in surgical patients? A meta-analytic study"},{"title3":"Clinical review: hemodynamic monitoring in the intensive care unit"},{"title3":"Intensive insulin therapy in critically ill patients"},{"title3":"Intensive versus conventional glucose control in critically ill patients"},{"title3":"Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data"},{"title3":"Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis"},{"title3":"Does enteral nutrition compared to parenteral nutrition result in better outcomes in critically ill adult patients? A systematic review of the literature"},{"title3":"A clinical and economic evaluation of enteral nutrition"},{"title3":"Early or late parenteral nutrition: ASPEN vs"},{"title3":"Diuretics, mortality, and nonrecovery of renal function in acute renal failure"},{"title3":"Meta-analysis of frusemide to prevent or treat acute renal failure"},{"title3":"The efficacy of loop diuretics in acute renal failure: assessment using Bayesian evidence synthesis techniques"},{"title3":"Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: a meta-analysis"},{"title3":"Adverse effects of antifungal therapies in invasive fungal infections: review and meta-analysis"},{"title3":"Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients"},{"title3":"Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures"},{"title3":"Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines"},{"title3":"Background fluctuation of kidney function versus contrast-induced nephrotoxicity"},{"title3":"Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial"},{"title3":"Contrast medium induced nephropathy in urological practice"},{"title3":"Renal effects of contrast media in diabetic patients undergoing diagnostic or interventional coronary angiography"},{"title3":"Contrast-induced nephropathy and its prevention: What do we really know from evidence-based findings?"},{"title3":"Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study"},{"title3":"Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease"},{"title3":"Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography"},{"title3":"Baseline renal function screening"},{"title3":"Pitfall in nephrology: contrast nephropathy has to be differentiated from renal damage due to atheroembolic disease"},{"title3":"Contrast medium-induced acute kidney injury: comparison of intravenous and intraarterial administration of iodinated contrast medium"},{"title3":"Persistent renal enhancement after intra-arterial versus intravenous iodixanol administration"},{"title3":"Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography"},{"title3":"Contrast-induced nephropathy:prevention and risk reduction"},{"title3":"Captopril for prevention of contrast-induced nephropathy in diabetic patients: a randomised study"},{"title3":"A randomized trial of saline hydration to prevent contrast-induced nephropathy in patients on regular captopril or furosemide therapy undergoing percutaneous coronary intervention"},{"title3":"PREPARED: Preparation for Angiography in Renal Dysfunction: a randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction"},{"title3":"A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity"},{"title3":"Importance of oral fluid intake after coronary computed tomography angiography: an observational study"},{"title3":"Oral hydration and alkalinization is noninferior to intravenous therapy for prevention of contrast-induced nephropathy in patients with chronic kidney disease"},{"title3":"A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients"},{"title3":"N-acetylcysteine in the prevention of contrast-induced nephropathy"},{"title3":"The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable"},{"title3":"Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful"},{"title3":"A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy: the Dialysis-versus-Diuresis (DVD) Trial"},{"title3":"Renal protection for coronary angiography in advanced renal failure patients by prophylactic hemodialysis. A randomized controlled trial"},{"title3":"Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients"},{"title3":"The prevention of radiocontrast-agent-induced nephropathy by hemofiltration"}]},{"title2":"Definition and classification of kidney diseases","References":[]},{"title2":"Criteria of drug-induced liver disorders. Report of an international consensus meeting","References":[]},{"title2":"Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury","References":[{"title3":"Idiosyncratic drug hepatotoxicity"},{"title3":"Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex"},{"title3":"Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations"},{"title3":"Outcome and prognostic markers in severe drug-induced liver disease"},{"title3":"Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period"},{"title3":"Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury"},{"title3":"Causes, clinical features and outcomes from a prospective study of drug-induced liver injury in the United States"},{"title3":"Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset"},{"title3":"Drug-induced chronic liver disease, with emphasis on chronic active hepatitis"},{"title3":"The natural history of histologically proved drug induced liver disease"},{"title3":"The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice"},{"title3":"Criteria of drug-induced liver disorders. Report of an International Consensus Meeting"},{"title3":"Outcome of acute idiosyncratic drug-induced liver injury: long-term follow-up in a hepatotoxicity registry"},{"title3":"Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct"},{"title3":"Case definition and phenotype standardization in drug-induced liver injury"},{"title3":"Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury"},{"title3":"Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)"},{"title3":"Causality assessment of adverse reactions to drugs I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries"},{"title3":"Long-term follow-up of patients with mild to moderate drug-induced liver injury"},{"title3":"Role of innate and adaptive immunity during drug-induced liver injury"},{"title3":"Drug-induced acute liver failure: results of a U. S. multicenter, prospective study"},{"title3":"Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis"},{"title3":"Acute liver injury associated with the use of ebrotidine, a new H2-receptor antagonist"},{"title3":"Rapid progression to liver cirrhosis of toxic hepatitis due to ebrotidine"},{"title3":"Chronic liver injury related to use of bentazepam: an unusual instance of benzodiazepine hepatotoxicity"},{"title3":"Hepatotoxicity associated with statin use: analysis of the cases included in the Spanish Hepatotoxicity Registry"},{"title3":"Possibly ranitidine-induced autoimmune hepatitis"},{"title3":"Isoniazidassociated hepatitis in 114 patients"},{"title3":"Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin"},{"title3":"Nitrofurantoin-induced chronic active hepatitis"},{"title3":"Hepatic injury associated with the use of nitrofurans: a clinicopathological study of 52 reported cases"},{"title3":"Liver damage from flucloxacillin, cloxacillin and dicloxacillin"},{"title3":"Liver cirrhosis induced by long-term administration of a daily low dose of amiodarone: a case report"},{"title3":"Methotrexate and histologic hepatic abnormalities: a meta-analysis"},{"title3":"Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis"},{"title3":"Ramiprilassociated hepatotoxicity"},{"title3":"Chronic active hepatitis associated with diclofenac sodium therapy"},{"title3":"Atorvastatin associated liver disease"},{"title3":"Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network"},{"title3":"Trimethoprim sulfamethoxazole-induced vanishing bile duct syndrome"},{"title3":"Prolonged cholestasis due to trimethoprim sulfamethoxazole"},{"title3":"Features and outcomes of 899 patients with drug-induced liver injury: The DILIN Prospective Study"},{"title3":"Chronic active cirrhogenic hepatitis induced by fenofibrate"},{"title3":"Drug-induced nodular regenerative hyperplasia"},{"title3":"Terbinafine hepatotoxicity resulting in chronic biliaryductopenia and portal fibrosis"},{"title3":"Terbinafine induced hepatitis with persistent cholestasis"}]},{"title2":"Kidney disease is associated with in-hospital death of patients with COVID-19","References":[]},{"title2":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","References":[]},{"title2":"Liver injury in COVID-19: management and challenges","References":[{"title3":"The cytokine storm and COVID-19"},{"title3":"Kidney diseases and COVID-19 infection: causes and effect, supportive therapeutics and nutritional perspectives"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"COVID-19 and liver disease"},{"title3":"COVID-19 and the liver"},{"title3":"Liver Dysfunction Is Associated with Long-Term Mortality in Septic Shock"},{"title3":"Review article: COVID-19 and liver disease-what we know on 1st May 2020"},{"title3":"Gastrointestinal and liver manifestations in patients with COVID-19"},{"title3":"Liver diseases in COVID-19: Etiology, treatment and prognosis"},{"title3":"COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies"},{"title3":"Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis"},{"title3":"Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis"},{"title3":"A Case Series of Children With 2019 Novel Coronavirus Infection: Clinical and Epidemiological Features"},{"title3":"Clinical characteristics of 82 cases of death from COVID-19"},{"title3":"Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large U.S. Cohort"},{"title3":"Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding"},{"title3":"SARS-CoV-2 Infection in Children"},{"title3":"Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study"},{"title3":"Clinical Features of COVID-19-Related Liver Functional Abnormality"},{"title3":"Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China"},{"title3":"Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area"},{"title3":"Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: a retrospective, multi-centre case series"},{"title3":"Longitudinal Association Between Markers of Liver Injury and Mortality in COVID-19 in China"},{"title3":"Liver tests abnormalities in COVID-19: trick or treat?"},{"title3":"Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic"},{"title3":"Health Status of Patients Who Underwent Liver Transplantation During the Coronavirus Outbreak at a Large Center in Milan, Italy"},{"title3":"COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission"},{"title3":"COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract"},{"title3":"Liver injury in COVID-19: management and challenges"},{"title3":"Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease"},{"title3":"Coronavirus infections and immune responses"},{"title3":"Apoptosis: a mechanism of acute and chronic liver injury"},{"title3":"SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases"},{"title3":"Proteomics. Tissue-based map of the human proteome"},{"title3":"COVID-19 in a designated infectious diseases hospital outside Hubei Province, China"},{"title3":"Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)"},{"title3":"A literature review for the mechanisms of stress-induced liver injury"},{"title3":"Mechanisms and treatment of organ failure in sepsis"},{"title3":"Liver - guardian, modifier and target of sepsis"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China"},{"title3":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase"},{"title3":"The emerging role of ACE2 in physiology and disease"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor"},{"title3":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein"},{"title3":"Human neutralizing antibodies elicited by SARS-CoV-2 infection"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes"},{"title3":"The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Subcutaneous administration of recombinant glycosylated interleukin 6 in patients with cancer: pharmacokinetics, pharmacodynamics and immunomodulatory effects"},{"title3":"A phase I trial of intravenous interleukin-6 in patients with advanced cancer"},{"title3":"Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells"},{"title3":"Systemic inflammation as fuel for acute liver injury in COVID-19"},{"title3":"Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality"},{"title3":"Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?"},{"title3":"Liver injury during highly pathogenic human coronavirus infections"},{"title3":"SARS-CoV-2: a storm is raging"},{"title3":"In the eye of the COVID-19 cytokine storm"},{"title3":"Viral and host factors related to the clinical outcome of COVID-19"},{"title3":"Alteration of Liver Biomarkers in Patients with SARS-CoV-2 (COVID-19)"},{"title3":"Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China"},{"title3":"Use of lactate dehydrogenase to evaluate the anti-viral activity against influenza A virus"},{"title3":"Lactate dehydrogenase leakage as a marker for apoptotic cell degradation induced by influenza virus infection in human fetal membrane cells"},{"title3":"Adipokines: molecular links between obesity and atheroslcerosis"},{"title3":"A new perspective on C-reactive protein in H7N9 infections"},{"title3":"C-reactive protein as a biomarker of severe H1N1 influenza"},{"title3":"Cognitive decline in Parkinson disease"},{"title3":"Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major U.S. Hospital Network"},{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"Digestive Manifestations in Patients Hospitalized With Coronavirus Disease 2019"},{"title3":"Effect of Gastrointestinal Symptoms in Patients With COVID-19"},{"title3":"Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study"},{"title3":"AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19"},{"title3":"Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study"},{"title3":"Don't Overlook Digestive Symptoms in Patients With 2019 Novel Coronavirus Disease (COVID-19)"},{"title3":"COVID-19 and liver injury: where do we stand?"},{"title3":"Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection"},{"title3":"Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China"},{"title3":"Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement"},{"title3":"COVID-19: Abnormal liver function tests"},{"title3":"Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19"},{"title3":"Hepatic manifestations of COVID-19"},{"title3":"Liver injury is associated with severe coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of retrospective studies"},{"title3":"Coronavirus disease 2019 and prevalence of chronic liver disease: A meta-analysis"},{"title3":"Acute Liver Failure in a COVID-19 Patient Without any Preexisting Liver Disease"},{"title3":"Nonalcoholic fatty liver disease is associated with COVID-19 severity independently of metabolic syndrome: a retrospective case-control study"},{"title3":"Hepatic Steatosis Is Associated with Increased Disease Severity and Liver Injury in Coronavirus Disease-19"},{"title3":"Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Among Patients With Preexisting Liver Disease in the United States: A Multicenter Research Network Study"},{"title3":"Gastrointestinal and Hepatic Manifestations of COVID-19: Evolving Recognition and Need for Increased Understanding in Vulnerable Populations"},{"title3":"Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study"},{"title3":"COVID-19 in solid organ transplant recipients: A single-center case series from Spain"},{"title3":"COVID-19 in solid organ transplant recipients: Initial report from the US epicenter"},{"title3":"COVID-19 in solid organ transplantation patients: A systematic review"},{"title3":"Tocilizumab and liver injury in patients with COVID-19"},{"title3":"A Novel Coronavirus from Patients with Pneumonia in China, 2019"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor"},{"title3":"A review of the safety of favipiravir - a potential treatment in the COVID-19 pandemic?"},{"title3":"Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19"},{"title3":"A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19"},{"title3":"Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavir"},{"title3":"Liver Injury in Critically Ill and Non-critically Ill COVID-19 Patients: A Multicenter, Retrospective, Observational Study"},{"title3":"Complex Drug-Drug-Gene-Disease Interactions Involving Cytochromes P450: Systematic Review of Published Case Reports and Clinical Perspectives"},{"title3":"Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies"},{"title3":"The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design"},{"title3":"Cytochrome P450-mediated drug interactions in COVID-19 patients: Current findings and possible mechanisms"},{"title3":"Remdesivir for the Treatment of Covid-19 - Final Report"},{"title3":"Remdesivir for 5 or 10 Days in Patients with Severe Covid-19"},{"title3":"Liver injury in remdesivir-treated COVID-19 patients"},{"title3":"Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019"},{"title3":"Etiology and management of liver injury in patients with COVID-19"},{"title3":"Therapeutic Potential for Tetracyclines in the Treatment of COVID-19"},{"title3":"Association between tetracycline or doxycycline and hepatotoxicity: a population based case-control study"},{"title3":"Azithromycin augments rhinovirus-induced IFNbeta via cytosolic MDA5 in experimental models of asthma exacerbation"},{"title3":"Randomized trial to evaluate azithromycin's effects on serum and upper airway IL-8 Levels and recurrent wheezing in infants with respiratory syncytial virus bronchiolitis"},{"title3":"Azithromycin for COVID-19: More Than Just an Antimicrobial?"},{"title3":"Challenges in COVID-19 drug treatment in patients with advanced liver diseases: A hepatology perspective"},{"title3":"Off-label use of tocilizumab in patients with SARS-CoV-2 infection"},{"title3":"First case of drug-induced liver injury associated with the use of tocilizumab in a patient with COVID-19"},{"title3":"Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics"},{"title3":"Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine"},{"title3":"Liver Injury in COVID-19: Caution and Management"},{"title3":"Perioperative Presentation of COVID-19 Disease in a Liver Transplant Recipient"},{"title3":"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)"},{"title3":"Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review"},{"title3":"Tocilizumab and COVID-19"},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV"},{"title3":"Case report on alimentary tract hemorrhage and liver injury after therapy with oseltamivir: A case report"},{"title3":"Polygalasaponin F treats mice with pneumonia induced by influenza virus"},{"title3":"Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study"},{"title3":"Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro"},{"title3":"The dual protease inhibitor lopinavir/ritonavir (LPV/r) exerts genotoxic stress on lung cells"},{"title3":"Ritonavir and Lopinavir Suppress RCE1 and CAAX Rab Proteins Sensitizing the Liver to Organelle Stress and Injury"},{"title3":"Challenges at the Time of COVID-19: Opportunities and Innovations in Antivirals from Nature"},{"title3":"Protective effect of bicyclol on lipopolysaccharide-induced acute lung injury in mice"},{"title3":"Ribavirin mode of action in chronic hepatitis C: from clinical use back to molecular mechanisms"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"Current pharmacological treatments for COVID-19: What's next?"},{"title3":"Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity"},{"title3":"COVID-19: A review of the proposed pharmacological treatments"},{"title3":"Chloroquine ameliorates carbon tetrachloride-induced acute liver injury in mice via the concomitant inhibition of inflammation and induction of apoptosis"},{"title3":"Chloroquine attenuates paraquat-induced lung injury in mice by altering inflammation, oxidative stress and fibrosis"},{"title3":"Prevention of respiratory syncytial virus infection with probiotic lactic acid bacterium Lactobacillus gasseri SBT2055"},{"title3":"The gut microbiota and host health: a new clinical frontier"},{"title3":"Contributions of the intestinal microbiome in lung immunity"},{"title3":"Rationale for the use of N-acetylcysteine in both prevention and adjuvant therapy of COVID-19"},{"title3":"Assessment of Renal and Hepatic Tissue-Protective Effects of N-Acetylcysteine via Ammonia Metabolism: A Prospective Randomized Study"},{"title3":"Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome?"},{"title3":"Multisociety Consensus Quality Improvement Revised Consensus Statement for Endovascular Therapy of Acute Ischemic Stroke"},{"title3":"Could Vitamins Help in the Fight Against COVID-19?"},{"title3":"Role of vitamin E in nonalcoholic fatty liver disease"},{"title3":"Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths"},{"title3":"Vitamin D and liver fibrosis: Molecular mechanisms and clinical studies"},{"title3":"Potential protection of vitamin C against liver-lesioned mice"},{"title3":"Zinc and COVID-19: Basis of Current Clinical Trials"},{"title3":"Zinc and liver disease"},{"title3":"Possibility of magnesium supplementation for supportive treatment in patients with COVID-19"},{"title3":"Magnesium and liver disease"},{"title3":"COVID-19: The Potential Role of Copper and N-acetylcysteine (NAC) in a Combination of Candidate Antiviral Treatments Against SARS-CoV-2"},{"title3":"Is copper beneficial for COVID-19 patients?"},{"title3":"Dose-related effects of dexamethasone on liver damage due to bile duct ligation in rats"},{"title3":"Corticosteroids in Acute Lung Injury: The Dilemma Continues"}]},{"title2":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia"},{"title3":"Structure, Function, and Evolution of Coronavirus Spike Proteins"},{"title3":"The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex"},{"title3":"Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion"},{"title3":"Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding"},{"title3":"Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen"},{"title3":"Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion"},{"title3":"Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains"},{"title3":"Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis"},{"title3":"cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination"},{"title3":"The 3.1-Angstrom Cryo-electron Microscopy Structure of the Porcine Epidemic Diarrhea Virus Spike Protein in the Prefusion Conformation"},{"title3":"Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy"},{"title3":"Pre-fusion structure of a human coronavirus spike protein"},{"title3":"Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide"},{"title3":"Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites"},{"title3":"Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation"},{"title3":"The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells"},{"title3":"Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2"},{"title3":"Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R"},{"title3":"Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody"},{"title3":"Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody"},{"title3":"Leginon: an automated system for acquisition of images from vitreous ice specimens"},{"title3":"Real-time cryo-electron microscopy data preprocessing with Warp"},{"title3":"Automatic local resolution-based sharpening of cryo-EM maps"},{"title3":"PHENIX: building new software for automated crystallographic structure determination"},{"title3":"ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps"},{"title3":"Coot: model-building tools for molecular graphics"},{"title3":"Collaboration gets the most out of software"},{"title3":"cisTEM, user-friendly software for single-particle image processing"}]},{"title2":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection","References":[{"title3":"WHO. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). 2020. https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov) (accessed Janaury 30, 2020)"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis"},{"title3":"Novel dynamics of human mucociliary differentiation revealed by single-cell RNA sequencing of nasal epithelial cultures"},{"title3":"Single-cell transcriptome analysis maps the developmental track of the human heart"},{"title3":"scRNA-seq assessment of the human lung, spleen, and esophagus tissue stability after cold preservation"},{"title3":"Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer"},{"title3":"Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations"},{"title3":"Single-cell analysis of Crohn's disease lesions identifies a pathogenic cellular module associated with resistance to anti-TNF therapy"},{"title3":"Single-cell transcriptomics of a human kidney allograft biopsy specimen defines a diverse inflammatory response"},{"title3":"Single-cell transcriptomic map of the human and mouse bladders"},{"title3":"Dimensionality reduction for visualizing single-cell data using UMAP"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"A protein complex in the brush-border membrane explains a Hartnup disorder allele"},{"title3":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9"},{"title3":"Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme"},{"title3":"Myocardial infarction increases ACE2 expression in rat and humans"}]},{"title2":"Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: a retrospective study","References":[{"title3":"Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias"},{"title3":"Liver injury during highly pathogenic human coronavirus infections"},{"title3":"Novel coronavirus pneumonia prevention and control program"},{"title3":"Pulmonary sequelae in convalescent patients after severe acute respiratory syndrome: evaluation with thin-section CT"},{"title3":"Preliminary study of the relationship between novel coronavirus pneumonia and liver function damage: a multicenter study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis"},{"title3":"Exploring the mechanism of liver enzyme abnormalities in patients with novel coronavirus-infected pneumonia"}]},{"title2":"Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target"},{"title3":"Podocyte disorders: core curriculum 2011"},{"title3":"Kidney disease is associated with in-hospital death of patients with COVID-19"}]},{"title2":"Predictors of mortality in Middle East respiratory syndrome (MERS)","References":[{"title3":"Middle East Respiratory Syndrome-Coronavirus (MERS-CoV): a case-controlstudy of hospitalized patients"},{"title3":"Predictors of MERS-CoV infection: a large case control study of patients presenting with ILI at a MERS-CoV referral hospital in Saudi Arabia"},{"title3":"A comparative study of clinical presentation and risk factors for adverse outcome in patients hospitalised with acute respiratory disease due to MERS coronavirus or other causes"},{"title3":"Differential Cell count and CRP level in Blood as predictors for Middle East respiratory syndrome coronavirus infection in acute febrile patients during nosocomial outbreak"},{"title3":"Managing MERS-CoV in the healthcare setting"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"High fatality rates and associated factors in two hospital outbreaks of MERS in Daejeon, the Republic of Korea"},{"title3":"A cohort-study of patients suspected for MERS-CoV in a referral hospital in Saudi Arabia"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications"},{"title3":"Clinical presentation and outcomes of Middle East respiratory syndrome in the Republic of Korea"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Imported cases of Middle East respiratory syndrome: an update"},{"title3":"Travel implications of emerging coronaviruses: SARS and MERS-CoV"},{"title3":"The characteristics of Middle eastern respiratory syndrome coronavirus transmission dynamics in South Korea"},{"title3":"Middle East respiratory syndrome coronavirus outbreak in the Republic of Korea"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): prevention in travelers"},{"title3":"Systematic review of emerging respiratory viruses at the Hajj and possible coinfection with Streptococcus pneumoniae"},{"title3":"Asymptomatic Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: extent and implications for infection control: a systematic review"},{"title3":"Epidemiology and predictors of survival of MERS-CoV infections in Riyadh region, 2014-2015"},{"title3":"Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections"},{"title3":"Influenza is more common than Middle East Respiratory Syndrome Coronavirus (MERS-CoV) among hospitalized adult Saudi patients"},{"title3":"Drivers of MERS-CoV transmission: what do we know?"},{"title3":"Middle East respiratory syndrome coronavirus: epidemiology and disease control measures"},{"title3":"Taking stock of the first 133 mers coronavirus cases globally-is the epidemic changing?"},{"title3":"State of knowledge and data gaps of Middle East respiratory syndrome coronavirus (MERS-CoV) in humans"},{"title3":"The predictors of 3- and 30-day mortality in 660 MERS-CoV patients"},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Renal complications and their prognosis in Korean patients with Middle East respiratory syndrome-coronavirus from the central MERS-cov designated hospital"},{"title3":"Critically ill patients with the Middle East respiratory syndrome"},{"title3":"Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus"}]},{"title2":"Clinical predictors of mortality of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: a cohort study","References":[{"title3":"Middle East Respiratory Syndrome-Coronavirus (MERS-CoV): a case-controlstudy of hospitalized patients"},{"title3":"Predictors of MERS-CoV infection: a large case control study of patients presenting with ILI at a MERS-CoV referral hospital in Saudi Arabia"},{"title3":"A comparative study of clinical presentation and risk factors for adverse outcome in patients hospitalised with acute respiratory disease due to MERS coronavirus or other causes"},{"title3":"Differential Cell count and CRP level in Blood as predictors for Middle East respiratory syndrome coronavirus infection in acute febrile patients during nosocomial outbreak"},{"title3":"Managing MERS-CoV in the healthcare setting"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"High fatality rates and associated factors in two hospital outbreaks of MERS in Daejeon, the Republic of Korea"},{"title3":"A cohort-study of patients suspected for MERS-CoV in a referral hospital in Saudi Arabia"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications"},{"title3":"Clinical presentation and outcomes of Middle East respiratory syndrome in the Republic of Korea"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Imported cases of Middle East respiratory syndrome: an update"},{"title3":"Travel implications of emerging coronaviruses: SARS and MERS-CoV"},{"title3":"The characteristics of Middle eastern respiratory syndrome coronavirus transmission dynamics in South Korea"},{"title3":"Middle East respiratory syndrome coronavirus outbreak in the Republic of Korea"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): prevention in travelers"},{"title3":"Systematic review of emerging respiratory viruses at the Hajj and possible coinfection with Streptococcus pneumoniae"},{"title3":"Asymptomatic Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: extent and implications for infection control: a systematic review"},{"title3":"Epidemiology and predictors of survival of MERS-CoV infections in Riyadh region, 2014-2015"},{"title3":"Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections"},{"title3":"Influenza is more common than Middle East Respiratory Syndrome Coronavirus (MERS-CoV) among hospitalized adult Saudi patients"},{"title3":"Drivers of MERS-CoV transmission: what do we know?"},{"title3":"Middle East respiratory syndrome coronavirus: epidemiology and disease control measures"},{"title3":"Taking stock of the first 133 mers coronavirus cases globally-is the epidemic changing?"},{"title3":"State of knowledge and data gaps of Middle East respiratory syndrome coronavirus (MERS-CoV) in humans"},{"title3":"The predictors of 3- and 30-day mortality in 660 MERS-CoV patients"},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Renal complications and their prognosis in Korean patients with Middle East respiratory syndrome-coronavirus from the central MERS-cov designated hospital"},{"title3":"Critically ill patients with the Middle East respiratory syndrome"},{"title3":"Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus"}]},{"title2":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong","References":[]},{"title2":"Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)","References":[]},{"title2":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health: the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Coronavirus infections: more than just the common cold"},{"title3":"Wuhan Municipal Health Commission. Report of clustering pneumonia of unknown etiology in Wuhan City. Published December 31, 2019. Accessed January 31, 2020. http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":" Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Published March 13, 2020. Accessed January 28, 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected"},{"title3":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (covid-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS"},{"title3":"A Novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"}]},{"title2":"Acute pneumonia and the cardiovascular system","References":[]},{"title2":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015","References":[{"title3":"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015"},{"title3":"Mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world: an update"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database"},{"title3":"Influenza infection and risk of acute myocardial infarction in England and Wales: a CALIBER self-controlled case series study"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"The art of modeling the mortality impact of winter-seasonal pathogens"},{"title3":"Seasonal influenza infections and cardiovascular disease mortality"},{"title3":"Influenza associated mortality in the subtropics and tropics: results from three Asian cities"},{"title3":"Circulating influenza virus, climatic factors, and acute myocardial infarction: a time series study in England and Wales and Hong Kong"},{"title3":"Mortality caused by influenza and respiratory syncytial virus by age group in England and Wales 1999-2010"},{"title3":"Mortality attributable to influenza in England and Wales prior to, during and after the 2009 pandemic"},{"title3":"Mortality attributable to 9 common infections: significant effect of influenza A, respiratory syncytial virus, influenza B, norovirus, and parainfluenza in elderly persons"},{"title3":"Global burden of influenza as a cause of cardiopulmonary morbidity and mortality"},{"title3":"Surveillance of antibiotic resistance"},{"title3":"The computation of equivalent potential temperature"},{"title3":"Third universal definition of myocardial infarction"},{"title3":"Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review"},{"title3":"Triggering of acute myocardial infarction by respiratory infection"},{"title3":"Acute cardiac injury events &lt;/=30 days after laboratory-confirmed influenza virus infection among U.S. veterans, 2010-2012"},{"title3":"Influenza and coronary artery disease: exploring a clinical association with myocardial infarction and analyzing the utility of vaccination in prevention of myocardial infarction"},{"title3":"Influenza, influenza-like symptoms and their association with cardiovascular risks: a systematic review and meta-analysis of observational studies"},{"title3":"Influenza vaccine as a coronary intervention for prevention of myocardial infarction"},{"title3":"Influenza vaccines for preventing cardiovascular disease"},{"title3":"A matched influenza vaccine strain was effective in reducing the risk of acute myocardial infarction in elderly persons: a population-based study"},{"title3":"Acute myocardial infarctions, strokes and influenza: seasonal and pandemic effects"},{"title3":"The causes and diagnosis of influenza-like illness"},{"title3":"Epidemiology of parainfluenza infection in England and Wales, 1998-2013: any evidence of change"},{"title3":"Relationship between supra-annual trends in influenza rates and stroke occurrence"},{"title3":"Role of acute infection in triggering acute coronary syndromes"},{"title3":"Complications and outcomes of pandemic 2009 influenza A (H1N1) virus infection in hospitalized adults: how do they differ from those in seasonal influenza"},{"title3":"Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection"},{"title3":"Influenza vaccination is associated with a reduced risk of stroke"},{"title3":"Influenza vaccination reduces hemorrhagic stroke risk in patients with atrial fibrillation: a population-based cohort study"},{"title3":"Influenza vaccination and cardiovascular risk in patients with recent TIA and stroke"},{"title3":"Comparison of two rapid influenza A/B test kits with reference methods showing high specificity and sensitivity for influenza A infection"},{"title3":"Model selection in time series studies of influenza-associated mortality"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies"},{"title3":"Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children"},{"title3":"Cardiovascular disease as a complication of community-acquired pneumonia"},{"title3":"Rationale and design of a randomized controlled trial of pneumococcal polysaccharide vaccine for prevention of cardiovascular events: the Australian Study for the Prevention through Immunization of Cardiovascular Events (AUSPICE)"},{"title3":"Association between pneumococcal vaccination and cardiovascular outcomes: a systematic review and meta-analysis of cohort studies"}]},{"title2":"An interferon-gamma-related cytokine storm in SARS patients","References":[{"title3":"The interferons and cell death: Guardians of the cell or accomplices of apoptosis?"},{"title3":"Interferon-gamma receptor 2 expression as the deciding factor in human T, B, and myeloid cell proliferation or death"},{"title3":"Infection of cultured intestinal epithelial cells with severe acute respiratory syndrome coronavirus"},{"title3":"Transforming growth factor-beta: A mediator of cell regulation in acute respiratory distress syndrome"},{"title3":"Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice"},{"title3":"Pegylated interferon-alpha protects type I pneumocytes against SARS coronavirus infection in macaques"},{"title3":"Dengue hemorrhagic fever in infants: A study on clinical and cytokine profiles"},{"title3":"Induction of interferon-inducible protein-10 and monokine induced by interferon-gamma from human endothelial cells infected with influenza A virus"},{"title3":"Roles of insulin-like growth factor I and transforming growth factor-beta in fibrotic lung disease"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Double-stranded RNA cooperates with interferon-gamma and IL-1 beta to induce both chemokine expression and nuclear factor-kappa B-dependent apoptosis in pancreatic beta-cells: Potential mechanisms for viral-induced insulitis and beta-cell death in type I diabetes mellitus"},{"title3":"Respiratory syncytial virus-induced chemokine production: Linking viral replication to chemokine production in vitro and in vivo"},{"title3":"Inflammatory cytokine profile in children with severe acute respiratory syndrome"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Dynamic changes in blood cytokine levels as clinical indicators in severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: A prospective study"},{"title3":"Development of a standard treatment protocol for severe acute respiratory syndrome"},{"title3":"Antigen-induced cell death of T effector cells in vitro proceeds via the Fas pathway, requires endogenous interferon-gamma and is independent of perforin and granzymes"},{"title3":"Inhibition of SARS Coronavirus infection in vitro with clinically approved antiviral drugs"},{"title3":"Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: The roles of cytokines and cellular immune activation in patients with pulmonary edema"},{"title3":"Dexamethasone inhibits lung epithelial cell apoptosis induced by IFN-gamma and Fas"},{"title3":"Plasma inflammatory cytokines and chemokines in severe respiratory syndrome"},{"title3":"Serologic and molecular biologic methods for SARS-associated coronavirus infection, Taiwan"},{"title3":"Early detection of antibodies against various structural proteins of the SARS-associated Coronavirus in SARS patients"},{"title3":"Analysis of serum cytokines in patients with severe acute respiratory syndrome"}]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Middle east respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways","References":[]},{"title2":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV","References":[{"title3":"Evaluation of serologic and antigenic relationships between Middle Eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses"},{"title3":"DNA vaccination: transfection and activation of dendritic cells as key events for immunity"},{"title3":"Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description"},{"title3":"Antibody response and disease severity in healthcare worker MERS survivors"},{"title3":"Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia"},{"title3":"High-resolution structure of HLA-A*1101 in complex with SARS nucleocapsid peptide"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests"},{"title3":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice"},{"title3":"Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection"},{"title3":"Response of memory CD8+ T cells to severe acute respiratory syndrome (SARS) coronavirus in recovered SARS patients and healthy individuals"},{"title3":"Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection"},{"title3":"SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex"},{"title3":"Identification of SARS-COV spike protein-derived and HLA-A2-restricted human CTL epitopes by using a new muramyl dipeptidederivative adjuvant"},{"title3":"Induction of T-cell response by a DNA vaccine encoding a novel HLA-A*0201 severe acute respiratory syndrome coronavirus epitope"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T Lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Rooting the phylogenetic tree of Middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat"},{"title3":"Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus"},{"title3":"Characteristics of traveler with Middle East respiratory syndrome, China, 2015"},{"title3":"The HLA-A2-supermotif: a QSAR definition"},{"title3":"The spike protein of SARS-CoV-a target for vaccine and therapeutic development"},{"title3":"Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC"},{"title3":"Vaccines for the prevention against the threat of MERS-CoV"},{"title3":"A 219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity"},{"title3":"Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells"},{"title3":"Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection"},{"title3":"Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection"},{"title3":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?"},{"title3":"Towards our understanding of SARS-CoV, an emerging and devastating but quickly conquered virus"},{"title3":"SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Identification of immunodominant epitopes on the membrane protein of the severe acute respiratory syndrome-associated coronavirus"},{"title3":"Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation"},{"title3":"From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses"},{"title3":"Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus"},{"title3":"Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses"},{"title3":"Improved transgenic mouse model for studying HLA class I antigen presentation"},{"title3":"Identification of residues of SARS-CoV nsp1 that differentially affect inhibition of gene expression and antiviral signaling"},{"title3":"Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA"},{"title3":"Clinical and laboratory findings of the first imported case of Middle East respiratory syndrome coronavirus to the United States"},{"title3":"Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a"},{"title3":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Tailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen"},{"title3":"Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the origin of the novel Middle East respiratory syndrome coronavirus"},{"title3":"Immunopathology of mouse hepatitis virus type 3 infection. Role of humoral and cell-mediated immunity in resistance mechanisms"},{"title3":"Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid"},{"title3":"T cell responses to whole SARS coronavirus in humans"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Recombinant duck enteritis viruses expressing major structural proteins of the infectious bronchitis virus provide protection against infectious bronchitis in chickens"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein"},{"title3":"Identification of an epitope of SARS-coronavirus nucleocapsid protein"},{"title3":"Functional and structural definition of a clustering region of HLA-A2-restricted cytotoxic T lymphocyte epitopes"},{"title3":"The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes"},{"title3":"Novel immunodominant peptide presentation strategy: a featured HLA-A*2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein"},{"title3":"Revival of the identification of cytotoxic T-lymphocyte epitopes for immunological diagnosis, therapy and vaccine development"},{"title3":"Characterization of human alphabetaTCR repertoire and discovery of D-D fusion in TCRbeta chains"},{"title3":"Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome"},{"title3":"Protective T-cell responses featured by concordant recognition of MERS-CoV-derived CD8+ T-cell epitopes and host MHC"},{"title3":"Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV"},{"title3":"Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond"},{"title3":"Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV"},{"title3":"Priming of CD8+ T cells during central nervous system infection with a murine coronavirus is strain dependent"},{"title3":"A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial"},{"title3":"Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity"},{"title3":"Serological assays for emerging coronaviruses: challenges and pitfalls"},{"title3":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity"},{"title3":"The structure and function of CD26 in the T-cell immune response"},{"title3":"Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection"},{"title3":"Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist"},{"title3":"Engineering T cells specific for a dominant severe acute respiratory syndrome coronavirus CD8 T cell epitope"},{"title3":"Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice"},{"title3":"Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea"},{"title3":"Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients"},{"title3":"Characterization of cytotoxic T-lymphocyte epitopes and immune responses to SARS coronavirus spike DNA vaccine expressing the RGD-integrin-binding motif"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Specific serology for emerging human coronaviruses by protein microarray"},{"title3":"Geographic distribution of MERS coronavirus among dromedary camels, Africa"},{"title3":"Defining CD8+ T cell determinants during human viral infection in populations of Asian ethnicity"},{"title3":"Structure of a SARS coronavirus-derived peptide bound to the human major histocompatibility complex class I molecule HLA-B*1501"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"A comprehensive comparison of transmembrane domains reveals organelle-specific properties"},{"title3":"Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system"},{"title3":"MERS in South Korea and China: a potential outbreak threat?"},{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"A new unconventional HLA-A2-restricted epitope from HBV core protein elicits antiviral cytotoxic T lymphocytes"},{"title3":"Evaluation of protective efficacy of the synthetic peptide vaccine containing the T-helper 1 epitope with CpG oligodeoxynucleotide against feline infectious peritonitis virus infection in cats"},{"title3":"Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study"},{"title3":"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution"},{"title3":"From SARS coronavirus to novel animal and human coronaviruses"},{"title3":"Structural and functional correlates of enhanced antiviral immunity generated by heteroclitic CD8 T cell epitopes"},{"title3":"HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins"},{"title3":"Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus"},{"title3":"Middle East respiratory syndrome and severe acute respiratory syndrome"},{"title3":"Protective efficacy of recombinant modified vaccinia virus ankara delivering Middle East respiratory syndrome coronavirus spike glycoprotein"},{"title3":"Identification of an HLA-A*0201-restricted CD8(+) T-cell epitope SSp-1 of SARS-CoV spike protein"},{"title3":"Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26"},{"title3":"MERS-CoV spike protein: targets for vaccines and therapeutics"},{"title3":"Serological study of an imported case of Middle East respiratory syndrome and his close contacts in China, 2015"},{"title3":"Origin and possible genetic recombination of the Middle East respiratory syndrome coronavirus from the first imported case in China: phylogenetics and coalescence analysis"},{"title3":"T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS"},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease"},{"title3":"Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia"},{"title3":"Immune responses to T-cell epitopes of SARS CoV-N protein are enhanced by N immunization with a chimera of lysosome-associated membrane protein"},{"title3":"Persistent memory CD4+ and CD8+ T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigen"},{"title3":"Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients"},{"title3":"Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Current advancements and potential strategies in the development of MERS-CoV vaccines"},{"title3":"Frequency, private specificity, and cross-reactivity of preexisting hepatitis C virus (HCV)-Specific CD8+ T cells in HCV-seronegative individuals: implications for vaccine responses"},{"title3":"Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus"},{"title3":"Passive immunotherapy with dromedary immune serum in an experimental animal model for Middle East respiratory syndrome coronavirus infection"},{"title3":"Airway memory CD4(+) T cells mediate protective immunity against emerging respiratory coronaviruses"},{"title3":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice"},{"title3":"The immune responses of HLA-A*0201 restricted SARS-CoV S peptide-specific CD8(+) T cells are augmented in varying degrees by CpG ODN, PolyI: C and R848"},{"title3":"CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein"},{"title3":"Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis"},{"title3":"Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes"},{"title3":"Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01"},{"title3":"Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines"}]},{"title2":"Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Consistent detection of 2019 novel coronavirus in saliva"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"},{"title3":"Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study"},{"title3":"Respiratory virus infection among hospitalized adult patients with or without clinically apparent respiratory infection: a prospective cohort study"},{"title3":"Additional molecular testing of saliva specimens improves the detection of respiratory viruses"},{"title3":"Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-polymerase chain reaction assay validated in vitro and with clinical specimens"},{"title3":"Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia"},{"title3":"Assessment of population susceptibility to upcoming seasonal influenza epidemic strain using interepidemic emerging influenza virus strains"},{"title3":"Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Efficacy of clarithromycin-naproxen-oseltamivir combination in the treatment of patients hospitalized for influenza A(H3N2) infection: an open-label randomized, controlled, phase IIb/III trial"},{"title3":"Treatment With lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset"},{"title3":"Molecular dynamic simulations analysis of ritonavir and lopinavir as SARS-CoV 3CL(pro) inhibitors"},{"title3":"Initial viral load and the outcomes of SARS"},{"title3":"Nasopharyngeal shedding of severe acute respiratory syndrome-associated coronavirus is associated with genetic polymorphisms"},{"title3":"Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes"},{"title3":"Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals"},{"title3":"Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection"},{"title3":"Analysis of intrapatient heterogeneity uncovers the microevolution of Middle East respiratory syndrome coronavirus"},{"title3":"Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis"},{"title3":"Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43"}]},{"title2":"Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019","References":[{"title3":"MERS-CoV diagnosis: an update"},{"title3":"Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses"},{"title3":"China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Potential rapid diagnostics, vaccine and therapeutics for 2019 novel coronavirus (2019-nCoV): a systematic review"},{"title3":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes"},{"title3":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003"},{"title3":"China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019"}]},{"title2":"Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019","References":[]},{"title2":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","References":[{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Haematological changes in patients with severe acute respiratory syndrome"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS)"},{"title3":"Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome"},{"title3":"Clinical presentations and outcome of severe acute respiratory syndrome in children"},{"title3":"Molecular pathways in virus-induced cytokine production"},{"title3":"Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?"},{"title3":"In vivo studies on cytokine involvement during acute viral respiratory disease of swine: troublesome but rewarding"},{"title3":"Host defense response and outcome in ARDS"},{"title3":"The role of chemokines in the immunopathology of pulmonary disease"},{"title3":"Severe acute respiratory syndrome (SARS)"},{"title3":"Clinical applications of cytokine assays"},{"title3":"Cytometric bead array to measure six cytokines in twenty-five microliters of serum"},{"title3":"The cytokines: physiological and pathophysiological aspects"},{"title3":"Differential role of interleukin-6 in lung inflammation induced by lipoteichoic acid and peptidoglycan from Staphylococcus aureus"},{"title3":"Interleukin-10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression"},{"title3":"IL-12: a key cytokine in immune regulation"},{"title3":"Interleukin-12 regulates the proliferation of Th1, but not Th2 or Th0, clones"},{"title3":"Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones"},{"title3":"Interleukin 12: a key modulator of immune function"},{"title3":"Interleukin-12. Biologic activity, therapeutic utility, and role in disease"},{"title3":"Chemokines in acute lung injury"},{"title3":"Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome"},{"title3":"Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance"},{"title3":"The role of neutrophil elastase in acute lung injury"},{"title3":"Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS"},{"title3":"GRO alpha and interleukin-8 in Pneumocystis carinii or bacterial pneumonia and adult respiratory distress syndrome"},{"title3":"Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome"},{"title3":"Phenotypic characterization of alveolar monocyte recruitment in acute respiratory distress syndrome"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Distinct functions of interferon-gamma for chemokine expression in models of acute lung inflammation"},{"title3":"Induction of cytokines in mice with parainfluenza pneumonia"},{"title3":"Invited review. Cytokine regulation of fever: studies using gene knockout mice"},{"title3":"Chemokines in infectious diseases of the lung"},{"title3":"Anti-interleukin 8 autoantibody: interleukin 8 complexes in the acute respiratory distress syndrome. Relationship between the complexes and clinical disease activity"},{"title3":"Transforming growth factor-beta: a mediator of cell regulation in acute respiratory distress syndrome"},{"title3":"The strategy of blocking the chemokine system to combat disease"},{"title3":"Antichemokine immunotherapy for allergic diseases"}]},{"title2":"MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile","References":[{"title3":"MERS coronavirus: diagnostics, epidemiology and transmission"},{"title3":"MERS-CoV: where are we now?"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Identification of residues on human receptor DPP4 critical for MERS-CoV binding and entry"},{"title3":"Emerging respiratory viral infections: MERS-CoV and influenza"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Middle East respiratory syndrome coronavirus &quot;MERS-CoV&quot;: current knowledge gaps"},{"title3":"2015 Middle East Respiratory Syndrome Coronavirus (MERS-CoV) nosocomial outbreak in South Korea: insights from modeling"},{"title3":"Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012"},{"title3":"The epidemiology of MERS-CoV"},{"title3":"Emerging viral respiratory tract infections-environmental risk factors and transmission"},{"title3":"Dromedary camels and the transmission of Middle East Respiratory Syndrome Coronavirus (MERS-CoV)"},{"title3":"A. Mailles, K. Blanckaert, P. Chaud, S. van der Werf, B. Lina, V. Caro, et al., First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European Communicable Disease Bulletin 18 (2013)."},{"title3":"J. Premila Devi, W. Noraini, R. Norhayati, C. Chee Kheong, A.S. Badrul, S. Zainah, et al., Laboratory-confirmed case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Malaysia: preparedness and response, April 2014. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 19 (2014)."},{"title3":"Tracing airline travelers for a public health investigation: Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection in the United States, 2014"},{"title3":"T. Briese, N. Mishra, K. Jain, I.S. Zalmout, O.J. Jabado, W.B. Karesh, et al., Middle East respiratory syndrome coronavirus quasispecies that include homologues of human isolates revealed through whole-genome analysis and virus cultured from dromedary camels in Saudi Arabia, mBio 5 (2014) e01146-e01214."},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): animal to human interaction"},{"title3":"MERS-CoV geography and ecology in the Middle East: analyses of reported camel exposures and a preliminary risk map"},{"title3":"Dromedary MERS-CoV replicates in human respiratory tissues"},{"title3":"Prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Abu Dhabi Emirate, United Arab Emirates"},{"title3":"Unraveling the drivers of MERS-CoV transmission"},{"title3":"Predictors of MERS-CoV infection: a large case control study of patients presenting with ILI at a MERS-CoV referral hospital in Saudi Arabia"},{"title3":"Infection control and MERS-CoV in health-care workers"},{"title3":"Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV)"},{"title3":"Renal complications and their prognosis in Korean patients with Middle East Respiratory Syndrome-Coronavirus from the central MERS-CoV designated hospital"},{"title3":"Acute management and long-term survival among subjects with severe Middle East Respiratory Syndrome coronavirus Pneumonia and Ards"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients"},{"title3":"Middle East respiratory syndrome coronavirus in Al-Madinah City, Saudi Arabia: demographic, clinical and survival data"},{"title3":"Guidelines for the laboratory diagnosis of Middle East respiratory syndrome coronavirus in Korea"},{"title3":"Cytometric bead array: a multiplexed assay platform with applications in various areas of biology"},{"title3":"Interferon-gamma: biologic functions and HCV terapy (type I/II) (2 of 2 parts)"},{"title3":"Safety, tolerability, and immunogenicity of interferons"},{"title3":"A tale of two cytokines: IL-17 and IL-22 in asthma and infection"},{"title3":"Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis"},{"title3":"Viral and cellular interleukin-10 (IL-10)-related cytokines: from structures to functions"},{"title3":"Infection-induced IL-10 and JAK-STAT: a review of the molecular circuitry controlling immune hyperactivity in response to pathogenic microbes"},{"title3":"MicroRNA regulation of viral immunity, latency, and carcinogenesis of selected tumor viruses and HIV"},{"title3":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Virus multiplicity of infection affects type I interferon subtype induction profiles and interferon-stimulated genes"},{"title3":"Interferon-stimulated genes response in endothelial cells following Hantaan virus infection"},{"title3":"Type I interferon induced epigenetic regulation of macrophages suppresses innate and adaptive immunity in acute respiratory viral infection"},{"title3":"T cell-, interleukin-12-, and gamma interferon-driven viral clearance in measles virus-infected brain tissue"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis"},{"title3":"Cytokine systems approach demonstrates differences in innate and pro-inflammatory host responses between genetically distinct MERS-CoV isolates"},{"title3":"Coronavirus virulence genes with main focus on SARS-CoV envelope gene"},{"title3":"Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells"},{"title3":"L. Josset, V.D. Menachery, L.E. Gralinski, S. Agnihothram, P. Sova, V.S. Carter, et al., Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus, mBio 4 (2013) e00165-e00213."},{"title3":"IL-17 cytokines in immunity and inflammation"},{"title3":"IL-10, T cell exhaustion and viral persistence"},{"title3":"Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction"},{"title3":"The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes"},{"title3":"Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins"},{"title3":"Interaction between STAT-3 and HNF-3 leads to the activation of liver-specific hepatitis B virus enhancer 1 function"},{"title3":"Hepatitis C virus targets the interferon-alpha JAK/STAT pathway by promoting proteasomal degradation in immune cells and hepatocytes"},{"title3":"Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling"},{"title3":"Tyrosine dephosphorylation of STAT3 in SARS coronavirus-infected Vero E6 cells"},{"title3":"IL-15-PI3K-AKT-mTOR: a critical pathway in the life journey of natural killer cells"},{"title3":"TLR-mediated activation of NK cells and their role in bacterial/viral immune responses in mammals"},{"title3":"The IL-12 family of cytokines in infection, inflammation and autoimmune disorders"},{"title3":"Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response"},{"title3":"Stimulation of IRF-7 gene expression by tumor necrosis factor alpha requirement for NFkappaB transcription factor and gene accessibility"}]},{"title2":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS","References":[{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"The SARS-CoV S glycoprotein: expression and functional characterization"},{"title3":"Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2"},{"title3":"Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"  : Severe acute respiratory syndrome (SARS): multi-country outbreak updated 34. http://www.who.int/csr/don/2003_04_02b/en/index.html."},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Fatal aspergillosis in a patient with SARS who was treated with corticosteroids"},{"title3":"Preparation and characterization of monoclonal antibodies against S1 domain at N-terminal residues 249 to 667 of SARS-associated coronavirus S1 protein"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Severe acute respiratory syndrome coronavirus fails to activate cytokine-mediated innate immune responses in cultured human monocyte-derived dendritic cells"},{"title3":"Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis"},{"title3":"Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells"},{"title3":"Clinical manifestations and inflammatory cytokine responses in patients with severe acute respiratory syndrome"},{"title3":"A probable role for IFN-gamma in the development of a lung immunopathology in SARS"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome"},{"title3":"Dynamic changes in clinical features and cytokine/chemokine responses in SARS patients treated with interferon alfacon-1 plus corticosteroids"},{"title3":"Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense"},{"title3":"Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?"},{"title3":"Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells"},{"title3":"TGF-beta 1 and IFN-gamma direct macrophage activation by TNF-alpha to osteoclastic or cytocidal phenotype"},{"title3":"Macrophages in inflammation"},{"title3":"TGF-beta 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells"},{"title3":"Science review: apoptosis in acute lung injury"},{"title3":"Role of vascular cell adhesion molecules and leukocyte apoptosis in the lymphopenia and thrombocytopenia of patients with severe acute respiratory syndrome (SARS)"},{"title3":"Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target?"},{"title3":"C-reactive protein as a marker for inflammatory bowel disease"},{"title3":"The IkappaB kinase is a key factor in triggering influenza A virus-induced inflammatory cytokine production in airway epithelial cells"},{"title3":"p38 mitogen-activated protein kinase-dependent hyperinduction of tumor necrosis factor alpha expression in response to avian influenza virus H5N1"},{"title3":"Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Longitudinal alteration of circulating dendritic cell subsets and its correlation with steroid treatment in patients with severe acute respiratory syndrome"},{"title3":"The relationship between serum interleukins and T-lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Recruitment and proliferation of T lymphocytes is supported by IFNgamma- and TNFalpha-activated human osteoblasts: involvement of CD54 (ICAM-1) and CD106 (VCAM-1) adhesion molecules and CXCR3 chemokine receptor"},{"title3":"Pathogenesis of HIV infection: what the virus spares is as important as what it destroys"},{"title3":"HIV: prevention of opportunistic infections"},{"title3":"High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome"},{"title3":"The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study"},{"title3":"Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids"},{"title3":"Drugs selectively blocking proinflammatory cytokines and cell receptors"},{"title3":"The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1:a review"}]},{"title2":"Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus","References":[{"title3":"ProMED-mail"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Novel coronavirus infection in the United Kingdom"},{"title3":"Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012"},{"title3":"Background and summary of novel coronavirus infection:as of 30 November 2012"},{"title3":"The severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans"},{"title3":"Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"The newly emerged SARS-Like coronavirus HCoV-EMC also has an &quot;Achilles' heel&quot;: current effective inhibitor targeting a 3C-like protease"},{"title3":"Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections"},{"title3":"Gene expression signature-based screening identifies new broadly effective influenza A antivirals"},{"title3":"Into the eye of the cytokine storm"},{"title3":"Discovery and preclinical validation of drug indications using compendia of public gene expression data"},{"title3":"Evaluation of the Calu-3 cell line as a model of in vitro respiratory syncytial virus infection"},{"title3":"Host regulatory network response to infection with highly pathogenic H5N1 avian influenza virus"},{"title3":"Release of SARS-CoV nuclear import block enhances host transcription in human lung cells"},{"title3":"Dynamic innate immune responses of human bronchial epithelial cells to severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Emerging role of ubiquitination in antiviral RIG-I signaling"},{"title3":"The connectivity map: a new tool for biomedical research"},{"title3":"Human coronavirus EMC is not the same as severe acute respiratory syndrome coronavirus"},{"title3":"Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential"},{"title3":"IL-17 boosts proinflammatory outcome of antiviral response in human cells"},{"title3":"Critical role of IL-17RA in immunopathology of influenza infection"},{"title3":"Regulation of epithelial immunity by IL-17 family cytokines"},{"title3":"The MHC class I antigen presentation pathway: strategies for viral immune evasion"},{"title3":"MHC class I antigen presentation: learning from viral evasion strategies"},{"title3":"Viral inhibition of MHC class II antigen presentation"},{"title3":"A comparison of the antigen-presenting capabilities of class II MHC-expressing human lung epithelial and endothelial cells"},{"title3":"Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Novel HIV-1 therapeutics through targeting altered host cell pathways"},{"title3":"The NF kappaB inhibitor SC75741 efficiently blocks influenza virus propagation and confers a high barrier for development of viral resistance"},{"title3":"The SARS-coronavirus-host interactome: identification of cyclophilins as target for Pan-coronavirus inhibitors"},{"title3":"Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506"},{"title3":"Effect of the phosphatidylinositol 3-kinase/Akt pathway on influenza A virus propagation"},{"title3":"Activation of the PI3K/Akt pathway early during vaccinia and cowpox virus infections is required for both host survival and viral replication"},{"title3":"Human cytomegalovirus Up-Regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling"},{"title3":"Effect of p38 mitogen-activated protein kinase on the replication of encephalomyocarditis virus"},{"title3":"The respiratory syncytial virus small hydrophobic protein is phosphorylated via a mitogen-activated protein kinase p38-dependent tyrosine kinase activity during virus infection"},{"title3":"Activation of the HIV-1 long terminal repeat by cytokines and environmental stress requires an active CSBP/p38 MAP kinase"},{"title3":"Mitogen activated protein kinase inhibitors: where are we now and where are we going?"},{"title3":"Development of PI3K inhibitors: lessons learned from early clinical trials"},{"title3":"Novel p38 MAPK inhibitor ML3403 has potent anti-inflammatory activity in airway smooth muscle"},{"title3":"Anti-inflammatory effect and selectivity profile of AS1940477, a novel and potent p38 mitogen-activated protein kinase inhibitor"},{"title3":"Design and synthesis of inhaled p38 inhibitors for the treatment of chronic obstructive pulmonary disease"},{"title3":"Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus"},{"title3":"Limma: linear models for microarray data"},{"title3":"Primer3 on the WWW for general users and for biologist programmers"},{"title3":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta delta C(T)) method"},{"title3":"Biomart:biological queries made easy"},{"title3":"Roles of p38 MAPK and JNK in TGF-beta1-induced human alveolar epithelial to mesenchymal transition"}]},{"title2":"Critical care management of adults with community-acquired severe respiratory viral infection","References":[{"title3":"Lower respiratory tract virus findings in mechanically ventilated patients with severe community-acquired pneumonia"},{"title3":"The role of human metapneumovirus in the critically ill adult patient"},{"title3":"Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options"},{"title3":"Hanfelt-Goade D, Maimon N, Nimer A, et al A phase 2b, randomized, double-blind, placebo-controlled trial of presatovir (GS-5806), a novel oral rsv fusion inhibitor, for the treatment of respiratory syncytial virus (RSV) in hospitalized adults American Thoracic Society 2018 international conference, San Diego, 2018: abstract A4457"},{"title3":"Efficacy and safety of nitazoxanide in addition to standard of care for the treatment of severe acute respiratory illness"},{"title3":"Advances in respiratory virus therapeutics:a meeting report from the 6th isirv Antiviral Group conference"},{"title3":"Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data"},{"title3":"Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a Global Patient Registry"},{"title3":"Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09"},{"title3":"Clinical practice guidelines by the infectious diseases society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenzaa"},{"title3":"High-dose versus standard dose oseltamivir for treatment of severe influenza in adult intensive care unit patients"},{"title3":"A prospective intervention study on higher-dose oseltamivir treatment in adults hospitalized with influenza a and B infections"},{"title3":"Comparison of high-dose versus standard dose oseltamivir in critically ill patients with influenza"},{"title3":"Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trial"},{"title3":"Impact of extracorporeal membrane oxygenation and continuous venovenous hemodiafiltration on the pharmacokinetics of oseltamivir carboxylate in critically ill patients with pandemic (H1N1) influenza"},{"title3":"Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A(H1N1) virus pneumonia"},{"title3":"Oseltamivir resistance in severe influenza A(H1N1)pdm09 pneumonia and acute respiratory distress syndrome: a French multicenter observational cohort study"},{"title3":"Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trial"},{"title3":"Evaluation of intravenous peramivir for treatment of influenza in hospitalized patients"},{"title3":"Influenza virus polymerase inhibitors in clinical development"},{"title3":"LB16. Phase 3 trial of baloxavir marboxil in high-risk influenza patients (CAPSTONE-2 study)"},{"title3":"Efficacy of clarithromycin-naproxen-oseltamivir combination in the treatment of patients hospitalized for influenza A(H3N2) infection: an open-label randomized, controlled, phase IIb/III trial"},{"title3":"Macrolide-based regimens in absence of bacterial co-infection in critically ill H1N1 patients with primary viral pneumonia"},{"title3":"Macrolides in critically ill patients with Middle East Respiratory Syndrome"},{"title3":"Early use of glucocorticoids was a risk factor for critical disease and death from pH1N1 infection"},{"title3":"The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09)-related critical illness"},{"title3":"The effect of steroid use in hospitalized adults with respiratory syncytial virus-related illness"},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients"},{"title3":"Corticosteroid therapy for critically ill patients with middle east respiratory syndrome"},{"title3":"Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection"},{"title3":"Hung IF, Wang To KK, Chan J, Chan KH, Yuen KY. ECCMID 2019. O0815 Treatment of severe influenza A infection with celecoxib. https://www.escmid.org. Accessed 14 Sep 2019"},{"title3":"Delayed oseltamivir plus sirolimus treatment attenuates H1N1 virus-induced severe lung injury correlated with repressed NLRP3 inflammasome activation and inflammatory cell infiltration"},{"title3":"Rapamycin adjuvant and exacerbation of severe influenza in an experimental mouse model"},{"title3":"Adjuvant treatment with a mammalian target of rapamycin inhibitor, sirolimus, and steroids improves outcomes in patients with severe H1N1 pneumonia and acute respiratory failure"},{"title3":"Simvastatin in the acute respiratory distress syndrome"},{"title3":"Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial"},{"title3":"Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection"},{"title3":"Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial"},{"title3":"Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial"},{"title3":"Effect of vitamin c infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI Randomized clinical trial"},{"title3":"Influenza coinfection: be(a)ware of invasive aspergillosis"},{"title3":"Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"Risk factors for noninvasive ventilation failure in critically ill subjects with confirmed influenza infection"},{"title3":"Effectiveness of noninvasive positive pressure ventilation in the treatment of acute respiratory failure in severe acute respiratory syndrome"},{"title3":"Transmission of severe acute respiratory syndrome during intubation and mechanical ventilation"},{"title3":"Noninvasive ventilation in critically ill patients with the Middle East respiratory syndrome"},{"title3":"Effect of noninvasive ventilation delivered by helmet vs face mask on the rate of endotracheal intubation in patients with acute respiratory distress syndrome: a randomized clinical trial"},{"title3":"High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure"},{"title3":"High-flow nasal therapy in adults with severe acute respiratory infection: a cohort study in patients with 2009 influenza A/H1N1v"},{"title3":"Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis"},{"title3":"Writing Group for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial I, Cavalcanti AB, Suzumura EA, Laranjeira LN, Paisani DM, Damiani LP, Guimaraes HP, Romano ER, Regenga MM, Taniguchi LNT, Teixeira C, Pinheiro de Oliveira R, Machado FR, Diaz-Quijano FA, Filho MSA, Maia IS, Caser EB, Filho WO, Borges MC, Martins PA, Matsui M, Ospina-Tascon GA, Giancursi TS, Giraldo-Ramirez ND, Vieira SRR, Assef M, Hasan MS, Szczeklik W, Rios F, Amato MBP, Berwanger O, Ribeiro de Carvalho CR, (2017) Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs low PEEP on Mortality in patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA 318:1335-1345"},{"title3":"Experience with high frequency oscillation ventilation during the 2009 H1N1 influenza pandemic in Australia and New Zealand"},{"title3":"High-frequency oscillation in early acute respiratory distress syndrome"},{"title3":"High-frequency oscillation for acute respiratory distress syndrome"},{"title3":"Severity of hypoxemia and effect of high-frequency oscillatory ventilation in acute respiratory distress syndrome"},{"title3":"Prone positioning in severe acute respiratory distress syndrome"},{"title3":"A multicenter retrospective review of prone position ventilation (PPV) in treatment of severe human H7N9 avian flu"},{"title3":"Neuromuscular blockers in early acute respiratory distress syndrome"},{"title3":"Early neuromuscular blockade in the acute respiratory distress syndrome"},{"title3":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome"},{"title3":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome and posterior probability of mortality benefit in a post hoc bayesian analysis of a randomized clinical trial"},{"title3":"Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1)"},{"title3":"Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus"},{"title3":"National Heart L, Blood Institute Acute Respiratory Distress Syndrome Clinical Trials N, Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF, Jr., Hite RD, Harabin AL, (2006) Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 354:2564-2575"},{"title3":"Right and left heart failure in severe H1N1 influenza A infection"},{"title3":"Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection"},{"title3":"Acute myocardial infarction after laboratory-confirmed influenza infection"},{"title3":"Cardiac manifestations in patients with pandemic (H1N1) 2009 virus infection needing intensive care"},{"title3":"Successful treatment of novel H1N1 influenza related fulminant myocarditis with extracorporeal life support"},{"title3":"Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review"},{"title3":"N95 respirators vs medical masks for preventing influenza among health care personnel: a randomized clinical trial"},{"title3":"Surgical mask vs N95 respirator for preventing influenza among health care workers: a randomized trial"},{"title3":"A cluster randomised trial of cloth masks compared with medical masks in healthcare workers"},{"title3":"Situations leading to reduced effectiveness of current hand hygiene against infectious mucus from influenza virus-infected patients"},{"title3":"WHO public health research agenda for influenza. https://www.who.int/influenza/resources/research/en/. Last accessed Jan 4-2020"}]},{"title2":"Early use of glucocorticoids was a risk factor for critical disease and death from pH1N1 infection","References":[]},{"title2":"Systemic corticosteroid therapy may delay viral clearance in patients with middle east respiratory syndrome coronavirus infection","References":[]},{"title2":"Corticosteroid therapy for critically ill patients with middle east respiratory syndrome","References":[]},{"title2":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients","References":[]},{"title2":"The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09)-related critical illness","References":[{"title3":"Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico"},{"title3":"World Health Organization. Pandemic (H1N1) 2009. Update 74. 13 November 2009. http://www.who.int/csr/don/2009_11_13/en/index.html. Accessed 22 February 2016."},{"title3":"World Health Organization, Global Influenza Surveillance and Response System (GISRS). Influenza laboratory surveillance information. http://gamapserver.who.int/gareports/Default.aspx?ReportNo=6. Accessed 22 February 2016."},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010"},{"title3":"Critical care services and 2009 H1N1 influenza in Australia and New Zealand"},{"title3":"Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids"},{"title3":"Effect of corticosteroid on lung parenchyma remodeling at an early phase of acute lung injury"},{"title3":"Do glucocorticoids decrease mortality in acute respiratory distress syndrome? A meta-analysis"},{"title3":"Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review"},{"title3":"Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome"},{"title3":"Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study"},{"title3":"Corticosteroid therapy for acute lung injury, acute respiratory distress syndrome, and severe pneumonia: a meta-analysis of randomized controlled trials"},{"title3":"Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial"},{"title3":"Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial"},{"title3":"Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis"},{"title3":"Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome"},{"title3":"Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis"},{"title3":"Human infection with a novel avian-origin influenza A (H7N9) virus"},{"title3":"Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome"},{"title3":"Corticosteroid therapy in patients with primary viral pneumonia due to pandemic (H1N1) 2009 influenza"},{"title3":"Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009"},{"title3":"Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores"},{"title3":"Corticosteroid therapy in intensive care unit patients with PCR-confirmed influenza A(H1N1) infection in Finland"},{"title3":"Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection"},{"title3":"Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain"},{"title3":"Impact of corticosteroid therapy on mortality in critically ill patients affected by influenza a (H1N1)v pneumonia in Spain [abstract 0931]"},{"title3":"InFACT: a global critical care research response to H1N1"},{"title3":"Pandemic Influenza Surveillance Guidelines. http://www.phac-aspc.gc.ca/cpip-pclcpi/ann-n-eng.php. Accessed 1 Mar 2016."},{"title3":"World Health Organization (WHO). Human infection with pandemic (H1N1) 2009 virus: updated interim WHO guidance on global surveillance. 10 July 2009. http://www.who.int/csr/disease/swineflu/WHO_case_definition_swine_flu_2009_04_29.pdf. Accessed 22 February 2016."},{"title3":"APACHE II: a severity of disease classification system"},{"title3":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine"},{"title3":"The occurrence and impact of bacterial organisms complicating critical care illness associated with influenza A(H1N1) infection"},{"title3":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors"},{"title3":"Immortal time bias in critical care research: application of time-varying Cox regression for observational cohort studies"},{"title3":"When is simple too simple? Immortal time bias in critical care"},{"title3":"A comparison of propensity score methods: a case-study estimating the effectiveness of post-AMI statin use"},{"title3":"Marginal structural models and causal inference in epidemiology"},{"title3":"Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men"},{"title3":"National Asthma Education and Prevention Program, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health. Expert panel report 3 (EPR 3): guidelines for the diagnosis and management of asthma. Bethesda, MD: NHLBI Information Center; 2007. http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm/. Accessed 22 February 2016."},{"title3":"Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008"},{"title3":"Canadian Thoracic Society Asthma Management Continuum - 2010 consensus summary for children six years of age and over, and adults"},{"title3":"Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care"},{"title3":"Making inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational research"},{"title3":"The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments"},{"title3":"Methods for dealing with time-dependent confounding"}]},{"title2":"Clinical and immunologic features in severe and moderate coronavirus disease 2019","References":[]},{"title2":"Interleukin-6 use in COVID-19 pneumonia related macrophage activation syndrome","References":[]}]}]}